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With an increasing population, there is a higher pressure on natural resources 
including water. Increased water consumption, altered hydrology and pollution, threaten the 
sustainability of aquatic ecosystems and water resources.  The increasing contamination of 
water resources with a diversity of priority and emerging chemicals of concern has created a 
need for innovative water treatment solutions. Although current technologies can remove 
some of these chemicals new and more effective treatment solutions are still required for 
both water and wastewater applications. Nanomaterials have been widely studied for their 
potential for photocatalytic removal of contaminants in water treatment applications. 
Unfortunately, the low efficiency and difficulty with recovery of the catalyst material have 
limited implementation at the industrial or municipal scale.  Functionalization of 
nanoparticles such as TiO2 is a possible mechanism to improve the efficiency of the 
photocatalytic reactions holds considerable promise for treatment applications.  
Plasmonic photocatalysis has widely been considered as a potential method to 
improve photocatalytic efficiency. Few studies have examined optimizations of the ratio of 
metal to metal-oxide in photocatalysts for improving the efficiency of photocatalytic 
reactions. In the current study, the ratio of silver was altered in zinc oxide nanoparticles and 
the photocatalytic efficiency determined. Silver-zinc oxide nanoparticles were 
hydrothermally synthesized beginning with zinc oxide nanoparticles blended with acid 
digester containing silver nitrate and methenamine (HMTA). Characterization of the 
synthesized nanomaterials found little difference in the bandgap (around 380 nm) of the 
different manufactured materials and the agglomeration levels of the nanomaterial, indicating 
a decrease in surface area and reactivity. However, this agglomeration was seen through all 
silver loadings, meaning that it is not a factor affecting the comparison of this study. A 
photocatalytic test was completed using six-cm collimated UV-LED beam (θbeam= 4 cm) light 
source setup with a heat sink, placed over a four-position magnetic stir plate (10.5 cm above 




300 mL solution of 0.5 mM terephthalic acid (TPA) to measure hydroxyl production through 
the conversion of TPA into hydroxyterephthalic acid (HTPA). The conversion rate constants, 
calculated using a zero-order reaction rate model, were compared.  An increase in silver 
resulted in an apparent increase in the photocatalytic efficiency of the nanomaterial as 
indicated by increased hydroxyl production. However, this did not result in a major change in 
the photocatalytic activity until the silver was greater than 700,000%. 
Previously published laboratory scale photocatalytic removal tests tend to use purified 
water as the matrix in experiments. However, actual industrial or municipal applications need 
to consider the natural waters and effluents that are a complex mixture of chemicals that can 
affect the efficiency of photocatalysts. Although nanoparticles have been proposed for the 
removal of emerging contaminants, such as pharmaceuticals, in water and wastewater few 
tests have been conducted under these actual conditions. The efficiency of TiO2 (P25) for the 
removal of representative pharmaceuticals in an actual wastewater matrix (i.e. Waterloo 
municipal wastewater effluent) was compared to the removal efficiency in pure (Milli-Q) 
water. Pharmaceutical removal tests were completed under UV light irradiation, and a model 
photocatalyst (P25) and compared to dark and non-photocatalyst conditions. After exposure 
to different periods of time the pharmaceuticals were isolated from solution using solid phase 
extraction (SPE) and quantified using liquid chromatography mass spectroscopy (LC-
MS/MS). The removal was measured by comparing the reduction in concentration using the 
first-order reaction rate constants.  Using UV irradiation combined with a photocatalyst 
removal of some pharmaceuticals to below the detection limit was observed in as little as 5 
minutes in Milli-Q water.  In contrast, in wastewater effluent photocatalysis removed fewer 
of the pharmaceutical compounds and there was an apparent decrease in the photocatalytic 
efficiency. The decrease in efficiency is likely due to the blocking of the UV light and 
scavenging of the generated reactive oxygen species by the organic matter in the wastewater 
effluent matrix. Although photocatalysis is a useful tool for the removal of pharmaceuticals 
from pure water matrices, the substantial decrease of the removal rate for a wastewater 




natural waters/effluents. The challenges surrounding the application of nanoparticles in 
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With an increasing population, water sources are strained due to higher demand and 
greater contamination of a variety of emerging chemicals of concern. Innovative treatment 
approaches are needed to ensure protection of the environment as well as downstream 
drinking water intakes. Photocatalysis using nanomaterials has been explored widely as a 
possible approach for treatment of a broad variety of environmental contaminants in water. To 
use photocatalysts in water treatment, functionalization’s may provide improved removal.  
The overall objective of this thesis is to improve the photocatalytic efficiency of zinc oxide 
nanomaterials through plasmonic photocatalysts and to test the efficacy of photocatalytic 
degradation of pharmaceuticals in wastewater effluent collected from a local wastewater 
treatment plant (Waterloo). 
Although the use of nanomaterials for photocatalytic water treatment applications has 
been widely researched for nearly 40 years (Cates, 2017) this extensive research base has not 
been effectively translated into industrial applications. Although many scientific challenges 
currently limit its application in water treatment this approach continues to hold considerable 
promise. Titanium dioxide nanomaterials have become the benchmark for studying 
photocatalytic efficiency, as it is commercially available as Degussa P25, nanoparticles with a 
primary particle size of 21-23 nm. However, many other metal-oxides also have 
photocatalytic potential, such as zinc oxide. Initial trials found a significant improvement in 
the conversion rate constant of terephthalic acid (TPA) into hydroxyterephthalic acid (HTPA) 
when using zinc oxide nanoparticles over P25. Zinc oxide nanoparticles were therefore 
proposed for further study for improving photocatalytic efficiency.  
Plasmonic photocatalysis can improve the photocatalytic efficiency by combining a 
metal with a metal-oxide semiconducting material. The blend of the elements enhances 
efficiency through both localized surface plasmon resonance (LSPR) and Schottky barrier 
effects. While studies are often completed using plasmonic photocatalysis, few studies have 
researched the optimal ratio of metal to metal-oxide nanomaterials to improve photocatalytic 




nitrate concentrations to create new materials and these applied in a photocatalytic reactor to 
find the ratio with an optimal conversion rate. Zinc oxide nanoparticles were combined with a 
solution of acid digester, containing silver nitrate and hexamethylenetetramine (HMTA). 
Different volumes of acid digester were used to load the zinc oxide with a range of silver. The 
photocatalytic efficiency of different silver loadings was tested by observing hydroxyl 
production through the conversion of terephthalic acid (TPA) into hydroxyterephthalic acid 
(HTPA).  
Research exploring photocatalytic removal of contaminants of interest in water 
treatment applications typically use pure water matrices (such as Mill-Q water) spiked with a 
single contaminant. These studies explore the mechanisms and efficiency for contaminant 
removal but do not represent the complexity of water matrices where treatment would be 
applied. The second component of this thesis tests the relative efficiency of photocatalytic 
removal of selected pharmaceuticals using TiO2 nanoparticles (P25) in both a pure water 
matrix and with wastewater effluent. The conversion rate constants (calculated using a first-
order reaction rate), for a variety of pharmaceuticals typically found in wastewater were 
compared under light and dark conditions. The various properties of pharmaceuticals will 
affect the overall photocatalytic removal of the compound. The charge of the pharmaceutical 
in solution is important because there is a dependence on surface adsorption for photocatalytic 
removal. Oppositely charged particles should enhance electrostatic attraction. The degradation 
rate constants were compared with the charges of the pharmaceuticals in solution to observe 
whether electrostatic attraction significantly affected photocatalytic degradation rate.  
1.1 Thesis Organization 
This thesis is organized with a literature review and two data/experimental chapters, 
each describing the major experiments conducted, followed by general conclusions and 
recommendations chapter. A brief overview of each chapter is listed below: 
• Chapter 1. Introduction: This chapter has an introduction to the thesis and outlines 




• Chapter 2. Literature Review: This chapter contains a brief introduction to the 
theory and challenges for application of nanoparticle photocatalytic processes for 
treatment of trace contaminants in water/wastewater. 
• Chapter 3. Functionalization of Zinc Oxide with Silver to Improve Efficiency of 
Hydroxyl Formation: This chapter contains the project that studies the use of 
plasmonic photocatalysis for improved hydroxyl production. 
• Chapter 4. Removal of Pharmaceuticals from Wastewater Effluent using 
Titanium Dioxide based Photocatalysis: This chapter outlines the project regarding 
the removal of pharmaceuticals using titanium dioxide photocatalysis from pure 
(Milli-Q) and wastewater effluent.  
• Chapter 5 Conclusions and Recommendations: This chapter includes the general 






Chapter 2 Literature Review 
This review was partially adapted from (Jaciw-Zurakowsky et al., 2019).   
Over the past number of years, there has been a vast increase in the strains placed on 
the environment, including our water sources. For the first time in history, over half of the 
population lives within an urban area. With an ever-increasing population, the demands for 
water and the usage requirements have changed. The United Nations has established 
Sustainable Development Goals (SDGs) as an urgent call for global partnership. The SDGs 
highlight areas that must be prioritized to ensure the protection of the environment and the 
improvement of life in both developing and developed countries. For water protection, SDG 6, 
Clean Water and Sanitation, and SDG 14, Life Below Water are of interest. New challenges in 
water treatment have surfaced with the increased population.  
Emerging contaminants, including pharmaceuticals and microtoxins, are subjects of 
interest due to the increased occurrence in Canadian freshwaters. These contaminants have 
demonstrated adverse effects on aquatic species, such as altered reproduction habits in fish 
species. Concentrations of less than one ng/L resulted in decreased egg fertilization and 
demasculinization in male fathead minnows (Pimephales promelas) (Parrott and Blunt, 2005). 
In humans, there is little knowledge surrounding the effects of chronic consumption of 
subtherapeutic concentrations of pharmaceuticals (Jones, Lester and Voulvoulis, 2005). 
Microcystins, produced by blue-green algae are common in Canada in the summer and fall 
months. Microcystins can have adverse effects on aquatic species and  these neurotoxins can 
cause neurodegeneration in humans (Kotak and Zurawell, 2007). The long term, low 
concentration effects of emerging contaminants on human health is not fully understood but 
may be detrimental. Current Canadian infrastructure lacks the required technology to achieve 
full removal of many of these emerging contaminants. Nanomaterial-based photocatalysis 
may provide a unique solution for difficult to remove emerging contaminants in both large 




2.1 Water Treatment in Canada 
In Canada, advanced oxidation processes are often applied during drinking water 
treatment. The sources for drinking water, especially surface water, are also where treated 
wastewater effluent is often deposited. However, groundwater used as drinking water sources 
may also be contaminated by wastewaters, and the diversity of contaminants they contain. It 
would therefore be ideal to treat and minimize contamination ‘at the source’. 
The typical wastewater treatment processes employed in Canada include several stages 
of treatment. Primary treatment methods involve the removal of large solids via screen 
filtering, flocculation and coagulation steps. Secondary treatment processes remove soluble 
organic matter that passed primary treatment and biological matter, including bacteria and 
viruses. This includes methods such as biofiltration or activated sludge. Tertiary treatment is 
the removal methods employed to remove specific contaminants and may include disinfection. 
The contaminants removed during tertiary treatment can include many but not all emerging 
contaminants (Nathonson and Ambulkar, 2018). Tertiary treatment, including advanced 
oxidation processes (AOPs), are rarely employed in wastewater treatment in Canada 
(Government of Canada, 2017). However, there is an increasing trend to include additional 
treatment to protect surface waters and drinking water sources. AOPs generate highly reactive 
species such as (primarily but not exclusively) hydroxyl radicals which then oxidize and 
ultimately decompose the target pollutants. Advanced oxidation processes are potentially 
beneficial because they often degrade trace organic contaminants (i.e. micropollutants) that 
are otherwise poorly removed by other treatment processes.  
2.2 Tertiary Water Treatment Methods 
Many tertiary (or additional) treatment processes depend on advanced oxidation 
processes (AOPs). Advanced oxidation processes can remove or transform organic matter in 
aqueous solutions by facilitating interactions with reactive oxygen species (ROS).  Dominant 
ROS are displayed in Figure 2-1, and includes oxygen, peroxide, the hydroxyl radical and the 






Figure 2-1 Common reactive oxygen species (ROS) and their electron structures. The 
red dot represents an unpaired electron. Image from Held (2015).  
AOPs may employ various materials based on the individual requirements of the 
application. Ozonation is a standard advanced oxidation process often employed in drinking 
water treatment but can potentially be used in wastewater.  Although ozone is highly effective, 
it can be costly (e.g. energy consumption), efficiency can affected by water quality and it can 
potentially produce toxic byproducts and be dangerous to operate (Tibbetts, 1995). Another 
AOP is the Fenton reaction, which involves the combination of hydrogen peroxide and a 
Fenton reagent (often Fe2+ or Fe3+). The Fenton reagents react with hydrogen peroxide to 
create two different reactive oxygen species, as demonstrated in Equation 1-1 and Equation 1-
2. 
𝑭𝒆𝟐+ +𝑯𝟐𝑶𝟐 → 𝑭𝒆
𝟑+ +𝑯𝑶 ∙ + 𝑶𝑯−  Equation 1-1 
𝑭𝒆𝟑+ +𝑯𝟐𝑶𝟐 → 𝑭𝒆




Industrial water treatment applications often use Fenton reactions. However, they carry 
limitations such as required elevated temperatures and limited operational pH (approximately 
3 (Tušar et al., 2011)) which leads to the need for constant acidic input, and a subsequent 
neutralization step. Iron also forms complexes with wastewater compounds, and the recovery 
of iron is limited. 
While most AOPs work well on their own, a combination of various advanced 
oxidation processes in a single treatment step often results in higher contaminant removal. For 
example, one may consider combining photocatalysis with hydrogen peroxide to increase the 
concentration of ROS in a solution, thereby increasing the overall contaminant removal. In 
many cases, the addition of light irradiation also increases the degradation rate. Other 
advanced oxidation processes include other UV based AOPs such as UV/persulfate, UV/para-
acetic acid (PAA), and UV/chlorine. 
2.3 UV Based Advanced Oxidation Processes 
Numerous AOPs utilize UV light irradiation, with the simplest being photolysis. 
Photolysis is the use of light to drive the degradation of chemicals, including contaminants, 
following either direct or indirect mechanisms. Direct photolysis occurs when the contaminant 
molecule absorbs light energy, causing the molecule to decompose. Indirect photolysis in 
natural waters involves the absorption of light energy by naturally occurring components in 
water, such as humic substances, that perform as photosensitizers to create the ROS that lead 
to contaminant degradation (Zepp, Baughman and Schlotzhauer, 1981). Nitrate is an example 
of a naturally occurring component that is a photosensitizer for the production of hydroxyl 
radicals (Foote et al., 1996). The dissolved organic matter generates reactive species when 
exposed to light irradiation. These reactive species then interact with the contaminant, driving 
its decomposition (Santoke and Cooper, 2017). Other dissolved organic matter contains a 
variety of functional groups that can increase photolysis activity; these functional groups 
include carbonyls, nitroaromatics, n-oxides, alkenes, aryl chlorides, and products with a weak 




photodegradation pathways can include hydroxyl additions on alkenes and decarboxylation 
(Kamat and Meisel, 2002). 
 Photocatalytic Mechanism 
Photocatalytic advanced oxidation processes involve the combination of a UV light 
source and a photocatalyst. The interaction of these two components create ROS, which 
interact with contaminants, driving their degradation. Photocatalysis follows a similar 
mechanism to photolysis. The photocatalytic nature of any material lies in the ability of the 
material to absorb light. Photocatalysts absorb light at specific energies that allow electrons in 
the valence band to ‘jump’ an energy level into the conduction band, leaving behind a hole. In 
the presence of water, the electron can react with O2 to create O2· radicals, and the hole can 
react with water molecules to form reactive hydroxyls, as demonstrated in Figure 2-2.  
 
 
Figure 2-2-2 Photocatalysis with a metal-oxide semiconductor. The separated electrons 




The generated ROS in the aqueous solution, are free to degrade contaminants. There are a 
variety of materials employed for their photocatalytic properties, including semiconducting 
materials. The most commonly studied photocatalyst is TiO2, though almost all metal-oxides 
can perform as photocatalytic semiconductors. The mechanism of photocatalysis was first 
proposed by Hermann and Folger in 1999, who divided the photocatalysis reaction into five 
steps, illustrated in Figure 2-3 (Herrmann, 1999; Kamat and Meisel, 2002; Chong et al., 
2010):  
1. Mass transfer of the organic contaminants (e.g., A) in the liquid phase to the TiO2 surface; 
2. Adsorption of the organic contaminants onto the photon activated TiO2 surface (i.e., 
Surface activation by photon energy co-occurs in this step); 
3. Photocatalysis reaction for the adsorbed phase on the TiO2 surface (e.g., A → B); 
4. Desorption of the intermediates(s) (e.g., B) from the TiO2 surface; 
5.  Mass transfer of the intermediate(s) (e.g., B) from the interface region to the bulk fluid.  
  
Figure 2-2-3: The five steps of the photocatalytic reaction, as proposed by Hermann and 
Folger. A represents the organic contaminant, and B represents the degradation 




In this mechanism, adsorption of the contaminant onto the photocatalyst is vital. 
Various models are used to describe this adsorption, including the Mars- Van Krevelen model, 
stationary-state adsorption, the Eley Rideal, and the Langmuir- Hinshelwood models for one 
or two types of adsorption (Mozzanega, Herrmann and Pichat, 1979). The most commonly 
used photocatalytic rate models are the Langmuir- Hinshelwood models, shown in Equation 2-
4. The first model describes the reaction rate, r, derived from the Langmuir- Hinshelwood 
isotherm for competition for one type of site (Equation 2-3), and the next describes the 
reaction rate, r, derived from the Langmuir-Hinshelwood isotherm for independent adsorption 

















 Equation 2-4 
The K in these cases refers to a pseudo-equilibrium constant, while the k refers to the 
elementary reaction rate constant. The P refers to the proportion of occupied sites, of the 
oxygen or the reactant, depending on the subscript. 
2.3.2  Mechanism of Contaminant Degradation 
The hydroxyl radical is the primary oxidant in photocatalytic systems (Turchi and 
Ollis, 1990). There are four proposed mechanisms for hydroxyl attack. In case one, the 
hydroxyl is adsorbed onto the photocatalyst and reacts with the adsorbed surface contaminant. 
The second case involves the reaction of free hydroxyl and an adsorbed contaminant. Case 
three involves an adsorbed radical reacting with a free contaminant. The final hydroxyl attack 
case is the interaction between unbound hydroxyls and contaminants (Turchi and Ollis, 1990). 
While there are reactions with other radicals, Turchi and Ollis (1990) demonstrated the 
dominance of hydroxyls as the primary oxidizing species by detection of hydroxyls as the 




photocatalyst surface hydroxylation for organic degradation. The kinetic isotope effect was 
studied using D2O and found a decrease in reaction rate when D2O replaced H2O in solution, 
demonstrating the importance of the hydroxyl formation step. Finally, the intermediates of 
contaminants are highly hydroxylated. 
The complete degradation of a compound is called mineralization. The formed 
hydroxyl radicals likely continually attack the compound byproducts until they are fully 
mineralized. Table 1 outlines the photocatalytic reaction scheme. Other radicals can react with 
contaminants and cause some of the removal mechanisms. However, the reaction is often 
adsorption dependent, as shown in hydroxyl attack cases one to three, where with the 
hydroxyl, the contaminant, or both molecules are adsorbed to the surface of the photocatalyst. 
The fourth hydroxyl attack case refers to unbound hydroxyl and contaminant interacting 
without adsorption. Adsorption is profoundly affected by the charge of the contaminant, 
where more oppositely polarized materials are more likely to absorb.  
Table 1: Mechanisms involved in the photocatalytic reaction, adapted from (Turchi and 
Ollis, 1990). Species in parenthesis may be adsorbed or in the aqueous phase. Oxygens 
with a subscript L refer to oxygens on the lattice. 




→  𝑒− + ℎ+ (T1-1) 
Adsorption 𝑂𝐿
2− + 𝑇𝑖𝐼𝑉 + 𝐻2𝑂 
↔  𝑂𝐿𝐻
− + 𝑇𝑖𝐼𝑉 ∙ 𝑂𝐻− 
𝑇𝑖𝐼𝑉 + 𝐻2𝑂 ↔  𝑇𝑖
𝐼𝑉 ∙ 𝐻2𝑂 
𝑠𝑖𝑡𝑒 + 𝑅𝐼 ↔ 𝑅1,𝑎𝑑𝑠 





Recombination 𝑒− + ℎ+ → ℎ𝑒𝑎𝑡 (T1-5) 
Trapping 𝑇𝑖𝐼𝑉 ∙ 𝑂𝐻− + ℎ+ ↔ 𝑇𝑖𝐼𝑉⌊𝑂𝐻∙ 
𝑇𝑖𝐼𝑉 ∙ 𝐻2𝑂 + ℎ






Reaction Stage Mechanism Equation 
Number 
𝑅1,𝑎𝑑𝑠 + ℎ
+ ↔ 𝑅 ∙1,𝑎𝑑𝑠
+  
𝑇𝑖𝐼𝑉 + 𝑒− ↔ 𝑇𝑖𝐼𝐼𝐼 
𝑇𝑖𝐼𝐼𝐼 + 𝑂2 ↔ 𝑇𝑖











𝑇𝑖𝐼𝑉⌊𝑂𝐻∙ + 𝑅1,𝑎𝑑𝑠 → 𝑇𝑖
𝐼𝑉 + 𝑅2,𝑎𝑑𝑠 
𝑂𝐻∙ + 𝑅1,𝑎𝑑𝑠 → 𝑅2,𝑎𝑑𝑠 
𝑇𝑖𝐼𝑉⌊𝑂𝐻∙ + 𝑅1 → 𝑇𝑖
𝐼𝑉 + 𝑅2 






Reaction of Other 
Radicals 
𝑒− + 𝑇𝑖𝐼𝑉 ∙ 𝑂 ∙2
−+ 2(𝐻+) ↔ 𝑇𝑖𝐼𝑉(𝐻2𝑂2) 
𝑇𝑖𝐼𝑉 ∙ 𝑂 ∙2
−+ (𝐻+) ↔ 𝑇𝑖𝐼𝑉(𝐻𝑂 ∙2) 
(𝐻2𝑂2) + (𝑂𝐻
∙) ↔ (𝐻𝑂 ∙2




2.3.3 Nanomaterial-Based Photocatalysis 
Nanomaterial-based photocatalysis was first introduced in 1972 by Akira Fujishima 
and Kenichi Honda. This original discovery has sparked over forty years of academic 
research. Nanophotocatalysts are required to absorb light to create ROS. The materials 
considered are semiconductors, with band gaps between 0.2 and 4.0 eV, relating to absorbed 
light energy in wavelengths less than approximately 310 nm (ultraviolet light range). Some 
examples of nanomaterial photocatalysts are titanium dioxide (TiO2), zinc oxide (ZnO), 
tungsten trioxide (WO3), and other metal-oxides. The most commonly researched 
nanomaterial for photocatalytic application is titanium dioxide nanoparticles. A frequently 
used titanium dioxide nanoparticles are Degussa P25 (P25), which many authors use 
interchangeably with the term ‘titanium dioxide nanoparticles.  
Nanomaterials used in advanced oxidation processes can be designed to consume low 
energy, be renewable and potentially cost effective. Nanomaterials therefore present an 




the light source, the target contaminants one wishes to remove, and the amount of pre-
treatment applied to the water solution needs to be considered. 
 Photocatalytic Light Sources 
 Many nanomaterials that behave as photocatalysts perform best in the presence of 
ultraviolet (UV) light irradiation. UV light has a wavelength between 10 and 400 nm, divided 
into the following sub-ranges: UV-A (400 nm -315 nm), UV-B (315 nm- 280 nm) and UV-C 
(280 nm – 200 nm), and UV-V (200 nm- 10 nm). Sunlight provides UV light, but the source 
of sunlight is intermittent. UV-based reactors require additional design constraints to transmit 
sunlight into a reactor. The nanomaterial can be modified to improve the adsorption bandgap, 
or by using an alternate light source to compensate for the lack of light provided by the sun in 
the UV range. Commercial and industrial water treatment systems use mercury arc lamps as a 
UV light source. The recent developments of UV light emitting diodes (UV-LEDs) have 
allowed for alternative designs that can increase reactor efficiency not previously attainable 
using mercury arc lamps and potentially longer lifetimes. UV LEDs consume less energy than 
mercury arc lamps, and with advancing technology and mercury mining regulations that limit 
or band the use of mercury in products, the use of UV-LEDs will become more favorable and 
cheaper in economies-of-scale. Recent advances have also allowed for the creation of UV-C 
LEDs, allowing effective disinfection of bacteria and viruses as well as the potential for 
enhanced photocatalytic activity (Eskandarian et al., 2016). 
 Target Contaminants 
The arguably most crucial consideration one must make when discussing 
nanomaterials in advanced oxidation processes is the target contaminant one wishes to 
remove. In advanced oxidation processes for the treatment of drinking water, key targets 
include pharmaceuticals and personal care products (PPCPs), cyanotoxins, and other emerging 
contaminants. A pharmaceutical is any chemical used for the diagnosis, treatment, alteration 
or prevention of disease. The consumption of pharmaceuticals is expected to increase with 




The charge of the contaminant is of crucial consideration when selecting the 
appropriate photocatalyst setup. Because photocatalytic efficiency is dependent on the 
adsorption properties of the photocatalyst, it is desirable to have a target contaminant that is of 
opposite charge to the photocatalyst. Opposite charges would increase electrostatic 
interactions, and chances of adsorption. Methods for manipulation of charges, including 
changing pH, are discussed further in Section 2.5.2. 
 Pre-treatment of Water Matrix 
 To ensure the effectiveness of photocatalytic treatment, the photocatalysis step should 
be applied after the water sample has undergone primary and secondary treatment steps. The 
influent water source, either wastewater or drinking water, contains scavenging species that 
decrease the efficiency of the AOP. Scavenging species refers to species that can also adsorb 
and react with the reactive oxygen species produced in AOPs before they interact with the 
target contaminant. While photocatalysis can degrade sizeable particulate matter, it would 
require an excessive amount of additional time and energy, being highly inefficient. The use 
of pre-treatment steps, such as coagulation, flocculation, and filtration, creates a more 
straightforward water solution for those compounds. These initial steps are necessary to 
ensure the efficient removal of smaller molecular size target contaminants by AOPs. 
2.4  Nanomaterials in Photocatalytic Water Remediation 
Numerous nanomaterials can be applied to perform water remediation. As previously 
mentioned, almost any metal-oxide material may perform photocatalytic water remediation. 
The most commonly studied nanomaterial is P25, or titanium dioxide nanoparticles. The use 
of P25 is likely due to their low cost, toxicity, availability and the fact that titanium dioxide 
was the first material considered for photocatalysis (Fujishima and Honda, 1972). Titanium 
dioxide has become the industry and research standard for photocatalytic treatment of both air 




While titanium dioxide has become the research standard, it does not mean that it is 
the superior photocatalyst. Photocatalytic efficiency, or the efficiency of ROS production, 
depends on numerous factors. For example, the introduction discussed the bandgap of 
materials. The bandgap is indicative of the energy that can be absorbed by a nanomaterial. 
Metal-oxide nanomaterials have numerous bandgaps associated with them, mostly on the 
range of 1.7 eV (CdSe) to 3.2 eV (ZnO, TiO2, WO3), as demonstrated in Figure 2-4. The 
nanomaterial selected should consider the light source available and be matched to the energy 
of the incoming light to be used. 
 
Figure 2-4: Bandgaps of Semiconductor photocatalysts and noble metal, adapted from 
(Zhang et al., 2013). 
 The wavelength of a light source is inversely correlated to the energy, as presented by 
Einstein’s equation (Equation 2-5). In this case, 𝜆 is the wavelength of the light source (in m), 
h is the Planck Constant with a value of 4.135667662 ×10-15 eV⸳s, and c is the speed of light 







 Equation 2-5 
 Titanium dioxide has a bandgap of 3.2 eV, illustrating that it best absorbs light at a 
wavelength of approximately 387 nm. Zinc oxide has a similar bandgap of 3.2-3.3 eV and 
therefore absorbs almost the same wavelength of light, around 391 nm (Srikant and Clarke, 
1998; Zhang et al., 2013). Other metal-oxides tend to have smaller bandgaps, which indicates 
lower energy and thus, longer wavelength light source. A longer wavelength light range 
approaches the visible light spectrum. A nanomaterial with a small bandgap would 
presumably be best for photocatalytic water remediation. However, other factors affecting the 
performance of ROS production show that the photocatalytic efficiency is not solely 
dependent on the bandgap of the photocatalyst. Section 1.5 further discusses the factors 
affecting photocatalytic efficiency. 
Because numerous factors affecting overall photocatalytic efficiency exist, one cannot 
state that a single material as the best performing. Research standards have selected titanium 
dioxide nanoparticles as a benchmark for performance measurement. Many studies have 
explored the photocatalytic potential of other metal-oxide materials and have demonstrated 
improved performance when compared to P25 (Shafaei, Nikazar and Arami, 2010). While 
improved photocatalytic activity is reported comparing to titanium dioxide as a benchmark, it 
is difficult to compare the reports to one another. The next section discusses photocatalytic 
efficiency and the reporting methods used.  
2.5 Photocatalytic Reaction Efficiency 
Many factors are essential to consider when optimizing the efficiency of a 
photocatalytic setup. A water matrix is complex, and the treatment methods applied to them 
must be sophisticated. When referring to photocatalytic efficiency, one must consider the rate 
of the reaction.  However, studies tend to report the reaction rate differently. There is an 
apparent lack of standardized reporting and testing methods and this lack of consistency 




efficiency is also affected by numerous factors, ranging from the concentration of the catalysts 
and contaminant to the presence of scavenging species. 
Table 2: Photocatalytic Efficiency Reporting Methods. Note the variation between 
methods of reporting. 






Calculated based on the order of 
conversion/ degradation.  
Percent Degradation 




Compares the amount removed in a 
standardized test over a specific 
amount of time 
Time for complete 
removal 
𝑠,𝑚, ℎ𝑟 Measures the time required for 




In a linear removal, compares the 
moles removed per unit time 
Mass Degradation 𝑢𝑛𝑖𝑡 𝑚𝑎𝑠𝑠 (𝑔)
𝑢𝑛𝑖𝑡 𝑡𝑖𝑚𝑒
 
In a linear removal, compares the 
mass removed per unit time 
Electric Energy per 




Electric energy per order (EEO) is 
the electric energy in kilowatt 
hours [kWh] required to degrade a 
contaminant C by one order of 
magnitude in a unit volume [e.g., 1 
m3 (1000 L)] [19] of contaminated 




Reporting Method Units Notes 
Photonic Efficiency 
𝜉 
𝜉 =  
𝑟𝑎𝑡𝑒 𝑜𝑓 𝑟𝑒𝑎𝑐𝑡𝑖𝑜𝑛 
𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑡 𝑙𝑖𝑔ℎ𝑡 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦
 
Photonic efficiency measures the 
number of incident photons that 
productively interact with the 
catalytic agent (Pelaez et al., 2012; 
Tokode et al., 2016). 
2.5.1 The Concentration of Catalyst and Contaminant 
The concentration of the catalyst directly relates to the rate of reaction. The presence 
of more catalysts results in an increase in surface area and ROS, thereby increasing the 
degradation of the contaminants. The adsorption of the photocatalyst to the contaminant 
increases the overall degradation of the contaminant. With a higher presence of photocatalyst, 
there is a higher amount of catalyst-contaminant interactions. Similarly, the concentration of 
the contaminant is also essential in the overall photocatalytic efficiency. A higher 
concentration of the contaminant will also increase the interaction of the contaminant with the 
photocatalyst, and the ROS produced by the photocatalyst (Kumar, 2017). 
2.5.2 pH, charge of contaminant and catalyst 
The pH of the solution is a critical factor. A high pH is indicative of an acidic solution, 
where there are many hydrogens in solution while a low pH is indicative of a low 
concentration of hydrogens, and subsequently, a large concentration of hydroxyls in solution. 
The pH of the solution will alter the effective charges of all molecules within the solution, 
including the charge of the catalyst and the contaminant. Because a more opposite charge will 
result in a higher electrostatic attraction between molecules, an ideal pH would result in a 
water matrix where the contaminant and the catalyst have opposite charges, increasing their 





The pH of wastewater solutions dramatically varies depending on the waste produced. 
The pH of some wastewater solutions can vary considerably e.g. 9.8 for textile wastes 
(Pekakis, Xekoukoulotakis and Mantzavinos, 2006), 8.5 for hospital wastewater (Sponza and 
Güney, 2017), and ranges in electronic manufacturing wastewater (stripper solution pH 9-11, 
developer pH 10-13 and the rinse solution can range from a pH of 4 to 10) (Chen, Ni and 
Chen, 2003).  The charge of the photocatalyst relates to the known isoelectric point associated 
with the photocatalyst. The isoelectric point indicates whether a particle will have a positive or 
a negative charge within the solution. The isoelectric (neutral) point of titanium dioxide is 
5.19, and of zinc oxide nanomaterials is 7.13 (Sayes et al., 2009). Because a charge opposite 
to the contaminant is desirable, either the photocatalyst selected, or the pH of a waste solution 
may be adjusted to optimize the degradation process. The charge of the nanomaterial in the 
solution may also influence the agglomeration potential. Whether the pH is larger or smaller 
than the isoelectric point (IEP), the agglomerates are lower than when the pH is equal to the 
IEP, the material largely agglomerates (Sayes et al., 2009). 
2.5.3 Size, Shape and Structure of Photocatalyst 
The reduction in the size of photocatalytic materials dramatically changes the reaction 
effectiveness. The primary benefit of scaling down technology is the increase in surface area 
that is associated with nanomaterials. Tušar et al, (2011) demonstrated that the use of 
nanoparticles as a Fenton-type catalyst allows for efficiency improvements associated with the 
application of nanoparticles due to increased surface area and decreased diffusional resistance. 
However, the increased benefits are no longer observed between particles in the nanometer 
size range. Mclaren et al., (2009), demonstrated little effect of size on photocatalytic activity 
for ZnO nanoparticles with primary particle sizes between 15 and 45 nanometers (Mclaren et 
al., 2009).   
The size of the particle also relates to the agglomeration potential of the photocatalyst. 
Agglomeration is disadvantageous due to the decrease in surface area that scaling down 




ability. The agglomeration of nanoparticles in solution can be controlled by changing the pH. 
The variation of pH changes the zeta potential of the nanoparticles, increasing interparticle 
electrostatic repulsion (Li et al., 2010). 
The shape of the nanomaterials will also affect the photocatalytic reaction efficiency. 
This is demonstrated by the decreased reaction rates associated with nanorods and nanotubes 
when compared to nanoparticles (Pavasupree et al., 2006). Finally, studies have shown that 
the crystal structure of the nanomaterial has an impact on photocatalytic ability. The structure 
of the nanomaterial will affect the bandgap of the material, the ability of the material to absorb 
light energy and the ability to create free oxygen radicals. For example, Degussa P25 is a 
blend of rutile and anatase titanium dioxide nanoparticles at a ratio of 70:30, or 80:20. For 
titanium dioxide, anatase is often the functional crystal structure, but rutile can be more 
effective in specific degradation tests (Prairie et al., 1993). However, a combination of rutile 
and anatase crystal phases results in enhanced charge carrier separation, increasing 
photocatalytic activity (Djurišić, Leung and Ng, 2014). 
The growth of crystal structures along different crystallographic faces can also affect 
the photocatalytic activity. For example, growth of zinc oxide along different crystallographic 
faces is demonstrated in Figure 2-5. The shortening along the [0001] direction resulted 
hexagonal plate-like particles over the rod-shaped morphology, which had an increasing 
proportion of polar faces at the surface. This shortening along the [0001] direction in zinc 
oxide resulted in increased reaction rate constants (Mclaren et al., 2009), demonstrating that 





Figure 2-5: Growth patterns of ZnO structures along different crystallographic faces. A 
shortening of the material along the [0001] axis resulted in an increased proportion of 
polar faces at the surface, which demonstrated superior photocatalytic activity. Adapted 
from  (Mclaren et al., 2009). 
2.5.4 Reaction Temperature 
The ideal reaction temperature for photocatalytic removal of contaminants is reported 
by (Kumar, 2017) to be between 20℃ and 80℃. At 20℃, the apparent activation energy 
cannot be overcome, and over 80℃, charge carrier recombination is promoted and adsorption 
of contaminants to the surface is decreased (Hashimoto, Irie and Fujishima, 2005; Kumar, 
2017). 
2.5.5 Inorganic Ions 
Inorganic ions, such as magnesium, zinc, iron, copper, bicarbonate, phosphate, nitrate, 
and chloride, may affect the performance of the photocatalyst due to their adsorption onto the 
surface of the photocatalyst. The effects of these inorganic ions vary, but both cations and 
anions have demonstrated some effect on photocatalytic efficiency. Copper, iron and 
phosphate are cations that have a substantial effect on photocatalytic ability, whereas calcium, 
magnesium and zinc demonstrated a little effect (Kumar, 2017). Anions, including nitrate, 




photocatalyst. The charge of the photocatalyst in solution will determine whether cations or 
anions will affect the surface activity, due to electrostatic attraction forces.   
2.5.6 Presence of ROS Scavengers/ Donors 
Other components within the matrix may also affect photocatalytic efficiency. These 
components behave as scavengers or donors of the ROS produced during the photocatalytic 
reaction. An example is that the addition of only 0.02% (v/v) methanol in water influenced 
photocatalytic degradation rates of pharmaceuticals (Arlos et al., 2017). Humic acids in a 
water matrix may act as photosensitizers, and generate additional ROS to concurrently 
perform indirect photolysis with photocatalysis (Zepp, Baughman and Schlotzhauer, 1981). 
The composition of the water matrix, therefore, can have a considerable effect of the 
photocatalytic reaction efficiency. 
2.5.7 The Light Source: Intensity and Wavelength 
Many nanomaterials that behave as photocatalysts perform best in the presence of 
ultraviolet (UV) light irradiation. Sunlight provides UV light, but sunlight is not consistently 
available in many regions. UV-based reactors require additional design constraints to transmit 
sunlight into a reactor. Mercury arc lamps are a common UV light source because of their 
high light intensity output; however, they consume a large amount of energy. The recent 
developments of UV light emitting diodes (UV-LEDs), mentioned in Section 2.3.3.1, have 
allowed for alternative designs that can increase reactor efficiency.  
2.6 The TPA Test: A test for hydroxyl production 
As previously mentioned, hydroxyl radicals are responsible for the bulk of 
contaminant removal (Turchi and Ollis, 1990). Terephthalic acid (TPA) is a probe often used 
to assess the generation of hydroxyl radicals in solution. Because hydroxyl radicals are the 
primary driver in contaminant degradation, the TPA test has become a standard to compare 
photocatalytic efficiency. As demonstrated in Figure 2-6, the presence of hydroxyl radicals 






Figure 2-6: The degradation of terephthalic acid (TPA) into hydroxyterephtalic acid 
(HTPA) and other products including 4-hydroxybenzoic acid (HBA), as demonstrated 
by (Černigoj, Kete and Štangar, 2010). 
HTPA can be measured using fluorescence. If samples are taken periodically, the 
concentration versus time curves obtained may be fit using a modified reaction model 
(Equation 2-6). The k1 is the rate of formation of HTPA, while k2 is the rate of consumption, t 
represents the amount of time that the reaction has undergone, published by Cernegoi et al. 
(Černigoj, Kete and Štangar, 2010). 
[𝑯𝑻𝑷𝑨] =  
𝒌𝟏
𝒌𝟐
(𝟏 − 𝒆−𝒌𝟐∙𝒕) Equation 2-6 
2.7 Commercialization Challenges and Solutions 
There are two main barriers to commercialization that exist for the implementation of 
photocatalysis in water treatment technologies. There is a relatively low photocatalytic 
efficiency that currently exists when using nanomaterials as photocatalyst. Additionally, there 
is a need to remove the suspended nanomaterials from the water solution afterwards. Overall, 
there is a tradeoff between efficiency and the need to remove nanomaterials. There are 
methods; however, that can individually improve upon each of the limitations, as discussed 
below. A study completed for the Canadian Water Network in 2004 concluded that 




in the treatment of drinking water’ (Cooper Langford, 2004), encouraging the continued 
research on improving photocatalytic water treatment methods.  
2.7.1 Photocatalyst Efficiency  
There are some ways to improve the efficiency of the photocatalyst. Improving light 
adsorption or decreasing the charge carrier recombination are two methods of improving 
efficiency. Current photocatalysts tend to absorb light in the UV range, with little absorption 
in the visible light range, as discussed in section 2.5.7. Charge carrier recombination occurs 
when the generated charge carriers recombine, releasing the absorbed energy in the form of 
heat, rather than generating ROS. Improvements of photocatalytic activity can include 
sensitization with light sensors, doping, or changing the shape of the material either by 
engineering defects, spatial structuring or by morphology enhancement (Djurišić, Leung and 
Ng, 2014).  Below is a discussion of methods of improving efficiency by heterojunctions offer 
improvements in both optimization opportunities. 
 Plasmonic photocatalysts 
Increasing the hydroxyl production efficiency of the nanoparticles will increase the 
overall photocatalytic efficiency. One of the most studied applications of efficiency 
enhancement is by the creation of plasmonic photocatalysts. Plasmonic photocatalysis 
improves photocatalytic efficiency and assists in the remediation of a variety of efficiency 
challenges (Zhang et al., 2013). In a plasmonic photocatalyst, noble metal nanoparticles 
(typically silver or gold) combine with a metal-oxide semiconductor. The blending of these 
two nanomaterials creates a Schottky junction and localized surface plasmon resonance 
(LSPR). A Schottky junction is the build-up of an electric field within the contact area 
between the noble metal and metal-oxide. This charge buildup forces the separation of 
electron and hole pairs, reducing recombination and thereby increasing the interaction of 
electrons and holes with the oxygen species in the aqueous environment (van Grieken et al., 
2009; He et al., 2010). The LSPR feature of plasmonic photocatalysts provides a variety of 




the photocatalytic efficiency. The LSPR can also enhance the absorption of light. There is also 
a reduction in the electron-hole diffusion length, meaning that the light reacts closer to the 
surface of the particle, decreasing the distance that the free radicals must move to interact with 
oxygen species. The LSPR effect creates a strong local electric field, encourages new 
electron-hole pair generation, heats the surrounding environment to increase the redox 
reaction rate, and polarizes nonpolar molecules for better adsorption (Hofstadler et al., 1994; 
Bohren and Huffman, 1998; Zhdanov, Hägglund and Kasemo, 2005; He et al., 2010; 
Christopher, Xin and Linic, 2011; Linic, Christopher and Ingram, 2011; Mubeen et al., 2011; 
Thomann et al., 2011; Wang, Liu and Chen, 2012; Zhang et al., 2013; Romeiro et al., 2018) 
Figure 2-7 illustrates a summary of the theorized benefits of plasmonic photocatalysis. There 
are numerous improvements to the photocatalytic activity made through surface plasmon 
resonance. 
 Research has enhanced photocatalytic efficiency by using plasmonic photocatalysis 
(Zhang et al., 2013). The fallbacks to plasmonic photocatalysis lay in the additional synthesis 





Figure 2-7: The beneficial effects and mechanisms associated with plasmonic 
photocatalysis. The benefits may be divided into metal-semiconductor junction (Schottky 
junction) and localized surface plasmon resonance (LSPR) effects. From (Zhang et al., 
2013). 
 Semiconductor-Semiconductor photocatalysis (p-n junctions) 
One challenge in photocatalyst efficiency is the factor of electron-hole recombination. 
When the charge carriers recombine, rather than interacting with external water sources or 
contaminants, there is a loss of energy in the form of heat. While this heat loss may be high 
enough to promote thermal degradation of the contaminants, it results in a much less efficient 
degradation method. As mentioned with plasmonic photocatalysis, the blending of two 
different materials may introduce four benefits. First, there is an enhanced charge carrier 
separation. Next, there is a rapid charge transfer and a longer lifetime of the charge carriers. 
Lastly, there is a separation of incompatible reduction and oxidation reactions in a small space 




 The two methods of increasing this charge carrier separation involve combining two 
metal-oxide semiconductors with different band gap energy levels. The difference in band gap 
energy levels separates the conduction and valence bands, causing the holes to travel to one 
material and the electrons to travel to the other. In this case, electrons move to the lower 
conduction band, and holes move to the higher valence band. Two metal-oxide 
semiconductors create a non-p-n-type heterojunction system. To further improve on this, a ‘p-
type’ and an ‘n-type’ semiconductor may be combined. A ‘p-type’ semiconductor has the 
dopant missing an electron (typically group 3 elements) in its outer energy level, causing holes 
to be the dominant carrier. An ‘n-type’ semiconductor is doped with a (typically group 5) 
element that has an excess of electrons in its outer shell. The excess electrons become the 
primary charge carriers. This phenomenon is referred to as electronic p-n junctions, 
demonstrated in Figure 2-8 (Wang et al., 2014). When excitation separates the charge carriers, 
electrons transfer to the conduction band (ECB) of the n-type semiconductor, and the holes 





Figure 2-8: Schematic of a p-n junction. This junction may be formed by blending two 
doped semiconductors, or by combining a metal with a metal oxide semiconductor. From 
(Wang et al., 2014). 
 Semiconductor- Carbon heterojunctions 
Additionally, a semiconductor combined with a carbon material adds heterojunction 
benefits. The carbon materials include activated carbon, graphene and carbon nanotubes 
(CNTs). In the case of activated carbon and CNTs, an increase in the surface area is attributed 
for the improvement in photocatalytic activity, namely due to the increased adsorption sites, 
explained by the Langmuir-Hinshelwood adsorption model, Equation 2-3 (Wang et al., 2014). 
CNTs have the additional functionality of their electronic properties. The electronic properties 
indicate that they may behave as a metal-metal-oxide semiconductor as discussed in 
plasmonic photocatalysis. The large area also adds a capability for storage of excessive 
electrons. Similarly, the unique one-dimensional structure of graphene exhibits an even more 
advanced electron mobility, allowing for it to enhance the beneficial effects of plasmonic 




carbon-based nanomaterials has made them accessible for research of photocatalytic activity 
improvement with a higher chance of commercialization due to decreased production costs. 
2.7.2 Recovery of Nanomaterials 
Nanomaterials, while highly effective at photocatalytic based AOPs, are at times 
themselves considered a contaminant and are costly. The recovery of nanomaterials from the 
setup is a challenge due to their small size and strong dispersion properties. Three common 
nanomaterial recovery methods include immobilizing the nanocatalyst, filtering out the 
nanomaterials, or functionalizing the nanomaterials into magnetic photocatalysts. 
  Immobilized Nanocatalysts 
 The simplest method to address the recovery of nanomaterials issue is to immobilize 
the nanoparticle. However, this identifies a massive engineering trade-off to avoid the need for 
recovery methods versus the substantial decrease in surface area. This balance has been 
studied by many researchers and dates back as far as 1994, when titanium dioxide coats fused 
silica glass fibres (Hofstadler et al., 1994). The silica glass fibres performed as optical fibres. 
Due to the optical nature, light irradiation immediately passes to the titanium dioxide without 
losing intensity by a first pass through the water matrix. The removal of the loss of light 
intensity compensated for the decreased surface area expected by immobilization of particles. 
This paper, however, notes the weakness in their comparisons due to the change in quantum 
yield between higher local light intensity and a decrease in illuminated photocatalyst 
(Hofstadler et al., 1994). With current advancements in the scientific understanding of 
photocatalysis and the increased electrical efficiency of UV LEDs, it is likely that this study 
could be repeated with UV LEDs to find an improved photocatalytic degradation efficiency. 
Exploration of  numerous other immobilization methods have been studied including the 
immobilization of zinc oxide on glass plates (Behnajady et al., 2007), and the immobilization 
of titanium dioxide in a catalytic wall and a fixed bed reactor (van Grieken et al., 2009). The 
immobilized zinc oxide on glass achieved complete removal of a dye compound, but there 




wall reactor configuration was found to be the most optimal when compared to the fixed bed 
reactor setup. The success of the wall reactor configuration has been attributed to the higher 
specific activity of titanium dioxide, maximized radiation absorption due to the configuration, 
and the stability of the Ag-TiO2 film (van Grieken et al., 2009). As discussed above, 
immobilization of nanoparticles involves a tradeoff between the decreased surface area and 
the removal of a need for nanomaterial recovery. However, immobilized photocatalytic 
nanomaterials remain as an attractive solution for the removal of contaminants not typically 
removed by conventional water treatment methods.  
 Membrane Filtration of Nanomaterials 
Freely suspended nanoparticles are often the most photocatalytically efficient. If a 
suspended nanoparticle setup is required, it may be best for the materials to be suspended and 
then filtered out from the treated water. The Photocat AOP+ platform, created by Purifics in 
London, Ontario, boasts the use of a slurry setup with titanium dioxide, followed by ceramic 
membrane filtration to perform multi-stage purification techniques. The setup presumably 
uses small photocatalysts to achieve a slurry suspension, though they do not specify a 
nanomaterial size. This setup exemplifies the ability to use a suspended nanomaterial for 
water treatment, though multi-stage filtration would be required to ensure full removal of 
contaminants. However, it is argued that while this filtration system may provide high 
contaminant removal, the process itself is not energy saving, as reported by Benotti et al. 
(Prairie et al., 1993). 
A heavily explored use of membranes combined with photocatalysts encourages the 
use of photocatalysts coated or blended into the material of the membrane itself. The setup not 
only allows for the potential of membrane filtration but also provides the advantage of 
reduced membrane fouling, which is currently a significant challenge in membrane 




 Magnetic Nanocatalysts 
 Another method used to tackle the barrier associated with recovery of nanoparticles 
from aqueous matrices is magnetization. When the particles are magnetized, an electric field is 
applied to recapture nanoparticles from the treated suspension. Nanosized iron oxide particles 
are naturally magnetic when found in specific ratios. Fe (II) and Fe (III) at a molar ratio of 1:2 
creates magnetite, a material that can perform as a Fenton catalyst and be subsequently 
removed by magnetic separation. In the presence of hydrogen peroxide, magnetite is not stable 
and is converted to maghemite in a surface to core reaction progression (Rusevova, Kopinke 
and Georgi, 2012). However, this does not affect the Fenton reaction efficiency. One can then 
conclude that it may be preferable to use maghemite initially to avoid this conversion step. 
Another typical application of magnetization is the use of core-shell nanostructures, where the 
core is magnetic, and the shell has photocatalytic activity. A prime example of core-shell 
magnetization is the study completed by He et al., which used a three-layer core-shell particle 
(He et al., 2010). The core contained magnetic iron (2,3) oxide (Fe3O4) coated with silicon 
dioxide (SiO2). The SiO2 acts as a protective layer to avoid chemical and photo dissolution of 
the iron oxide. The outer shell contained titanium dioxide, which performed as the 
photocatalytic layer. These core-shell particles performed better than Degussa P25 and had the 
additional functionality of recovery from the solution. Magnetically charged nanoparticles are 
beneficial for two reasons. Firstly, because they can be separated and recycled from the 
sludge, they provide a sustainable water treatment method. Secondly, the sludge setup 
maximizes surface area, allowing the nanoparticle to perform photocatalysis at its highest rate. 
 
2.8 Emerging Contaminants: Pharmaceuticals and Personal Care Products 
Pharmaceuticals and personal care products (PPCPs) are widely considered to be 
emerging contaminants. The Food and Drugs act classifies many PPCPs as a ‘Drug.’ The 




“A drug includes any substance or mixture of substances manufactured, sold or 
represented for use in (a) the diagnosis, treatment, mitigation or prevention of a disease, 
disorder or abnormal physical state, or its symptoms, in human beings or animals, 
(b) restoring, correcting or modifying organic functions in human beings or animals, or 
(c) disinfection in premises in which food is manufactured, prepared or kept; (drogue)” 
(Revised Statute of Canada, 1985). 
This definition encompasses numerous compounds; they have substantial variability in 
structure, function, and activity. The use of pharmaceuticals is expected to increase with an 
ageing population and the recent publishing of the human genome (Jones, Voulvoulis and 
Lester, 2005). The expanded use of PPCPs creates a water treatment challenge that is 
expanding and diverse. There are over 3000 pharmaceutical compounds licensed in the United 
Kingdom alone, and the term pharmaceuticals and personal care products (PPCPs) blankets 
thousands of unique compounds. The properties of the pharmaceutical compounds range in 
numerous properties, including hydrophilicity and polarity. It is therefore impossible to 
identify one physical property of a pharmaceutical that can be used to target removal 
processes for them from wastewater. However, using the physicochemical properties of the 
pharmaceutical will be most useful. Physiochemical properties include chemical structure, 
aqueous solubility, octanol/water partition coefficient and Henry’s law constant (Jones, 
Voulvoulis and Lester, 2005). Other factors affecting the removal efficiency of these 
compounds include pH, retention time, temperature and amount of solids present (Jones, 
Voulvoulis and Lester, 2005). The range of physicochemical properties of pharmaceutical 
compounds contributes to a complex wastewater matrix. 
2.8.1 Environmental Effects 
Pharmaceuticals in the environment may impose serious toxic and other effects on 
aquatic species. Most effluents have a low concentrations of pharmaceuticals but approach or 
exceed the concentrations that have been reported to have effects in aquatic species in  lab 
tests (Arnold et al., 2014). For example, feminization of fish, identified in studies worldwide, 
including the demasculinization of fathead minnows. A controlled dose study of  fathead 




complete collapse of the fathead minnow population in as little as two years (Kidd et al., 
2007). Antidepressants have also caused a decrease in fish brain serotonin levels and 
predation behavior at concentrations seen in wastewaters (Bisesi, Bridges and Klaine, 2014). 
The effect of pharmaceutical compounds in effluents will vary between the species, the 
gender, mobility, the breeding habits of the species as well as the characteristics of the 
chemical. 
2.8.2 Challenges in the Treatment of Pharmaceuticals 
Pharmaceuticals provide a unique challenge to water treatment due to their structural 
variability, their conjugation and their low concentrations. As previously mentioned, there is a 
large variability in the structure of pharmaceutical compounds. Variation in properties 
includes their size, hydrophilicity and charge. Because there is a substantial number of 
pharmaceuticals consumed daily, it is infeasible to create a water treatment system specialized 
for the removal of all pharmaceuticals.  An additional problem is that PPCPs are conjugated in 
the body, to enhance their polarity before excretion. Once these conjugated pharmaceuticals 
pass through water treatment, they become deconjugated, and therefore the active compound 
may be released into  the environment (Ternes, Joss and Siegrist, 2004). Alternatively while 
the body can degrade pharmaceuticals, some compounds may be excreted unchanged (Jones, 
Voulvoulis and Lester, 2005). 
There are three proposed fates of pharmaceuticals when passing through a wastewater 
treatment plant. The first option is that the compound is partially degraded or mineralized. 
Secondly, the compound may not degrade but may partition to the sludge. The last possible 
fate of a pharmaceutical compound is that it passes through the wastewater treatment plant 
and ends up in the receiving waters (Klavarioti, Mantzavinos and Kassinos, 2009). 
Numerous studies on the elimination of high to medium polarity pharmaceuticals have 
found that their removal is often incomplete, ranging from 60-90% (Jones, Voulvoulis and 
Lester, 2005). The reason for the difficulty of removal is hypothesized to be due to various 




degradation processes and usually escape intact from conventional treatment plants. Also, 
pharmaceuticals are typically present at minute concentrations, making them incredibly 
difficult to detect. The pharmaceuticals can also affect the wastewater treatment process itself. 
Certain pharmaceuticals, such as antibiotics have the potential to disturb the community in 
sewage treatment systems, as well as inhibit the wastewater bacteria although they are usually 
well below this concentration threshold (Jones, Voulvoulis and Lester, 2005).  
2.8.3 Challenges in laboratory pharmaceutical photocatalysis setups 
Many studies have been completed to assess the removal of pharmaceuticals using 
photocatalysis. There are however many challenges in using a laboratory setup, which makes 
it challenging to compare the studies and to connect the studied results to applicability in 
municipal treatment. Some of the challenges are identified below: 
• Typical removal tests use pure water matrices, with a spike of the contaminant in 
question. While these tests give insight into the removal mechanisms of the 
contaminant, they fail to represent the surface water, or municipal wastewater where 
these tests would be applied. The pure water matrices do not consider the other 
compounds and contaminants included in a wastewater/ drinking water matrix.  
• Section 1.5 Photocatalytic Reaction Efficiency discusses the most common factors 
associated with altering photocatalytic efficiency. Laboratory tests often isolate one 
factor to optimize the photocatalytic efficiency. The individual reported removal rates 
are incomparable. Also, as demonstrated in Table 2, the methods of reporting removal 
or removal efficiency are inconsistent, also making it a challenge to identify the actual 
usefulness of the test.  
• While AOPs can be a tertiary treatment step in water treatment, scavenging species 
remain in the matrix that can affect the photocatalytic efficiency. Scavengers can 
include natural organic matter (NOM). Because many laboratory tests use pure water, 




• Additionally, the pH of the solution dramatically affects the photocatalytic efficiency. 
The pH will affect the electrostatic charge of both the catalyst and the contaminant and 
will affect their electrostatic interactions. In a tertiary step, chemical addition can 
adjust the solution pH. The adjustment of pH may require a significant addition of 
chemicals, which would make the process massively inefficient. Laboratory tests that 
use a pH adjusting method should consider this inefficiency. 
• Another challenge with standard removal tests is the lack of a standardized testing 
apparatus. Lack of standardization involves differences in light sources, causing 
changes in light intensity and emission wavelength. Even if the nanoparticle were 
standardized to have a similar primary particle size, differences in the bandgaps of 
various metal-oxides would respond differently to different wavelengths of light. 
Further, the concentrations of the catalyst and the contaminants are also rarely 
standardized. Overall, the high variability in testing conditions limit authors to 
conclude that their nanoparticle may show improved photocatalytic activity, but only 
in specific scenarios. 
• As previously mentioned, pharmaceuticals have wide structural variability and 
physiochemical properties. While photocatalytic removal of pharmaceuticals is widely 
studied, the individual pharmaceuticals selected vary. A review completed on titanium 
dioxide based photocatalytic removal identified diclofenac, ibuprofen, naproxen, and 
paracetamol as commonly tested pharmaceuticals. It was concluded that while 
photocatalysis shows promise in pharmaceutical removal, the inconsistencies in 
removal rates, extent of mineralization and photoproduct formation demonstrates the 
extent of the complexity of the behavior of drug removal (Kanakaraju, Glass and 
Oelgemo, 2014). An additional review completed found 38 papers that used zinc oxide 
based photocatalysis for the removal of a wide variety of pharmaceuticals. This review 
found a similar degree of inconsistencies in the studies, but additionally identified the 
complexity of natural organic matter, and the low concentrations at which 




studies explore the photocatalytic removal of pharmaceuticals, but as the reviews 
identified, there is little consistency in testing and reporting that make the removal 
rates comparable.  
Therefore, studies should aim to test pharmaceutical degradation in a manner that 
makes their findings comparable to other studies and represents the natural organic matter and 
other complexing agents that exist in wastewater and surface waters. Consideration factors 
should include that there is a likelihood that a preferential degradation will occur for the least 
stable pharmaceutical and the pharmaceutical that best adsorbs to the catalyst surface. 
Photocatalytic degradation studies should select a few representative pharmaceuticals based 
on their effective charge in solution, their typical persistence through water treatment 
processes and their potential adverse environmental effects.  
2.9 Summary 
In summary, photocatalysis continues to be a promising area of research for tertiary 
water treatment applications. Nanomaterials may provide a large improvement to the 
efficiency of ROS production due to its increased surface area. UV LEDs have provided 
opportunity for the exploration of energy effective photocatalytic applications. There are 
numerous factors affecting the photocatalytic reaction efficiency of the water matrix including 
the concentration of the catalyst and contaminant, the pH and electrostatic interactions 
between the catalyst and the contaminants, the size shape and structure of the photocatalyst, 
the reaction temperature, the presence of inorganic ions and scavengers and donors and the 
light source. The photocatalytic efficiency of materials is often assessed by the hydroxyl 
production, which is probed using TPA, which is converted into HTPA in the presence of 
hydroxyl radicals. Currently, challenges remain in the municipal use of nanomaterials in water 
treatment processes, including the photocatalytic efficiency and the need to remove 
nanomaterials from the treatment setup. The photocatalytic efficiency can be improved by 




metals. Nanomaterials may be removed from setup by immobilization, membrane filtration or 
using magnetism. 
Common contaminants that may be removed by nanomaterial based photocatalysis are 
pharmaceutical compounds. Pharmaceutical compounds cause an adverse effect on aquatic 
species but are difficult to remove from wastewater effluent due to their unique properties. 
Additionally, research completed using nanomaterial based photocatalysis for the removal of 
pharmaceuticals is not representative of the removal capabilities in municipal wastewater 






Functionalization of Zinc Oxide with Silver to Improve Efficiency of 
Hydroxyl Formation 
3.1 Introduction 
Photocatalysis is an advanced oxidation process that can be used to remove 
compounds from water matrices that are difficult to remove with other processes. The use of 
photocatalysts for water treatment has rarely been operationalized in industrial or utility 
(municipal) applications. One of the limiting factors is low photocatalytic efficiency for the 
removal of target chemicals. This efficiency is affected by both the ability of the 
nanomaterials to absorb light and the ability to produce reactive oxygen species. Plasmonic 
photocatalysis has been widely considered as a potential approach for improving the 
photocatalytic efficiency. Plasmonic photocatalysis provides improvement to the 
photocatalytic efficiency through both a Schottky Junction and LSPR effects (Zhang et al., 
2013). 
While plasmonic photocatalysts is often reported to have improved photocatalytic 
activity when compared to an un-doped metal oxide, few tests have been performed to find the 
best ratio of metal: metal-oxide composition. A limited number of studies have been 
completed that tested silver- zinc oxide plasmonic photocatalysts for improved photocatalytic 
activity (Table 3) and only two studies have compared different amounts of silver loading. It 
is difficult to compare the studies due to differences of morphology, synthesis methods, 
loading percentage, and photocatalytic testing methods. The morphologies of the materials can 
differ and can include nanospheres or nanorods. Every study completed also used a different 
synthesis method. The difference in synthesis methods are of concern due to differences in 
how the silver loading is reported. The percentage of silver loading reported is based on the 
amount of silver precursor (silver nitrate, silver acetate, or pre-synthesized silver 
nanospheres). Different synthesis methods can result in different binding efficiencies of the 




another. The reported photocatalytic efficiency was also tested using different methods 
including time for removal and percent degradation. The many differences in these studies 
therefore makes them difficult to compare directly.  
In the study completed herein, zinc oxide-silver nanoparticles were created using a 
hydrothermal synthesis method beginning with zinc oxide nanoparticles and a silver 
precursor. The hydroxyl production capability of the synthesized nanomaterials was tested 
using a common photocatalytic test, the TPA conversion test to determine the conversion rate 
constant (i.e.  the conversion of terephthalic acid (TPA) into hydroxyterephthalic acid 
(HTPA)). 
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3.2 Materials and Methods 
3.2.1 Synthesis of Silver-Zinc Oxide Nanomaterials 
Zinc oxide nanopowder (ZnO, 99+%, 10-30 nm) was purchased from US Research 
Nanomaterials, Inc. Silver nitrate was purchased from Alfa Aesar, and 
hexamethylenetetramine (HMTA) was purchased from Sigma Aldrich.  The hydrothermal 
synthesis method is detailed in Appendix A2: Hydrothermal Synthesis. The nanoparticles 
were synthesized by blending an appropriate amount of acid digester solution, composed of 
silver nitrate and HMTA. A range of different acid digester volume was added to a constant 
amount of zinc oxide nanoparticles to create a range of silver: zinc oxide ratios. The HMTA 
served as a reducing agent for the loading of the silver with the ratios are as outlined in Table 




Blue M furnace (Thermo Electron Corporation). The furnace was held at 100℃ for four hours 
and then left to cool for around three hours until the pressure decreased enough to open the 
vessel. The nanoparticle solution was then mixed with pure water for five minutes and 
purified using centrifugation and suction filtration through a 47 mm glass fiber filter (PALL 
Life Sciences).  
Table 4: The percent ratios (in Moles and Mass) of the synthesized Ag-ZnO Particles. 
These ratios were calculated by dividing the amount of silver by the amount of zinc 




























3.2.2 Conversion Test 
The photocatalytic ability of the synthesized silver-zinc oxide nanoparticles was tested 
using a TPA conversion test, a standard test to confirm photocatalytic efficiency. The 
photocatalytic test setup, demonstrated in Figure 2-1, consists of an in-house assembled six-
cm collimated UV-LED beam (θbeam= 4 cm) light source setup with a heat sink, placed over a 
four-position magnetic stir plate (10.5 cm above the surface of the water). A detailed 
procedure is outlined in A1: TPA to HTPA Conversion Protocol. In summary, 20 mg of the 
silver-zinc oxide nanoparticles were added to a 300 mL solution of 0.5 mM TPA. The solution 
was placed in a 400 mL beaker wrapped with foil, then left to stir on a stir plate for 60 min for 
adsorption to take place. At time 0, the UV lights were turned on. Samples were taken 
periodically for 10 min. pH was measured before and after the test, and the fluorescence of the 
HTPA was measured using a SpectraMax M3 plate reader. A depiction of the conversion test 
setup can be found in Figure 3-1. The conversion plots were then fit using a linear first order 
conversion rate. An ANOVA followed by Bonferroni tests were completed to determine 






Figure 3-1 Photocatalytic setup of the TPA conversion test. The test of each nanoparticle 
was completed in triplicate, as demonstrated by the three beakers. 
Due to the linearity of the conversion during the first 10 min of the reaction, a zero-
order reaction equation (Equation 2.1) was determined using the linest function in Microsoft 
Excel (Office 365). 𝑘 is the conversion rate constant (units: 1/min), [A]0 is the initial 
concentration of HTPA measured in solution. A stabilization period of 60 minutes was 
completed before the UV-LED was turned on at time 0.  
[𝑨] =  [𝑨]𝟎 + 𝒌𝒕  Equation 2-1: Zero Order Reaction Equation 
3.2.3 Characterization of Nanomaterials 
Diffuse reflectance spectroscopy (DRS) was used to determine the bandgap of the 
synthesized nanoparticles. The DRS spectra was collected using a Shimadzu UV-2501PC UV-
Visible-NIR spectrophotometer equipped with an integrating sphere accessory, using N2(g) as 
the reference. Details on the sample preparation, characterization and results can be found in 
Appendix A3: UV- Diffuse Reflectance Spectroscopy B3: DRS Data. Scanning Electron 




the WATLab at the University of Waterloo. An agglomeration test was also completed using a 
VASCO™ Particle size analyzer and NanoQ V2.5.9.0 software by Cordouan Technologies. 
3.3 Results 
Overall, an increased amount of silver loading on zinc oxide nanoparticles resulted in 
an increased hydroxyl production rate, as demonstrated by the reaction rate constant k (1/min) 
determined based on the first-order reaction rate fit the conversion of TPA into HTPA. 
Characterization of the nanoparticles found high agglomeration, and no change in the bandgap 
of various silver loadings.   
3.3.1 Conversion Rates 
Rapid hydroxyl formation was demonstrated by measuring the conversion of TPA into 
HTPA. Within the first ten minutes of the reaction, a linear conversion was observed. An 
example of the conversion using 100% Ag/ZnO nanoparticles is presented in Figure 3-2.  
Longer times for the reaction resulted in a non-linear relationship, likely as a result of the 
removal of HTPA once the concentrations increased and/or the depletion of the TPA. The 
typical pseudo-first order reaction model proposed by Černigoj et. Al (2010) could not be  be 
fit to the data to estimate the rate constants for TPA conversion  (Appendix B4) The rate 







Figure 3-2: The conversion of TPA into 2-HTPA over a time of 10 minutes. The test was 
completed in triplicate (Beakers 1 through 3). A linear conversion is observed, as 
demonstrated by the high R2 associated with the linear trendlines.   
The conversion rates (k in Equation 2-1) for the various molar percentages of the 
nanomaterials is shown in Figure 3-3. Each of the tests was completed in triplicate, and the 
average of the three conversion rate constants is reported with the standard deviations. As can 
be observed, there is a general increase in the conversion rate constant with increasing silver 
loading on the nanoparticles. An ANOVA of the conversion rates found statistically 
significant differences among the treatment groups. A Bonferroni test, comparing the 
conversion rates to a control of pure zinc oxide, found consistent statistical improvement in 
the conversion values for silver mass loadings of 5.06% and higher. A general increase in 
conversion rates can be observed with increased silver loadings. The pattern is disrupted at 
7.23E-02% and 1.01%, where a sharp increase in the conversion rate constant was observed. 
These increases may have occurred due to a difference in testing pH observed during the tests 







































Figure 3-3: The average conversion rate constants (k) versus the molar ratios of silver: 
zinc oxide nanoparticles. The error bars represent the standard deviation between the 
three tests completed. The red square represents pure zinc oxide, as purchased, which 
when tested had a significantly low standard deviation.  
3.3.2 Characterization of Nanomaterials 
DRS measurements confirmed a bandgap ranged from 368.4 to 394.2 with a mean 
value of 380.2 nm for each nanoparticle configuration (Appendix B3). This is comparable 
with the reported bandgap of 3.3 eV (375.7 nm) for zinc oxide (Srikant and Clarke, 1998). A 
linear regression found that the F-statistic was not significant, and there was no correlation 
between the silver molar percentage and the change in bandgap. The average bandgap of 
380.2 nm is close to the UV LED light source of 365 nm, indicating that the zinc oxide 
nanoparticles can absorb the light provided by the test setup. 
SEM images displayed high agglomeration of the nanoparticles. Due to the low 
concentrations of silver, there was no silver peak in the XPS measurements of the 50% and 


































percentage of AgZnO at low and high magnification. Figure 3-5 represents the 100-molar 
percentage AgZnO. As can be seen, both loadings have high levels of agglomeration, 
indicating a decreased surface area, and therefore reactivity of the nanoparticles. The imaging 
demonstrates that the shape of the synthesized nanoparticles remained spherical. This 
demonstrates that with a range of silver loading, the physical properties of the photocatalyst 







Figure 3-4: SEM images at A) 2000x magnification and B) 27 640x magnification of the 50 molar 
percentage of Ag-ZnO nanoparticle. High agglomeration can be seen in A, and a close up of that 
agglomeration can be seen in B. 
.
 
Figure 3-5: SEM images at A) 2950x magnification and B) 20 000x magnification of the 100 molar 
percentage Ag-ZnO nanoparticles. Agglomerated particles are still visible in A. 
 
 




The agglomeration of select silver molar percentage nanoparticle blends was also 
tested using a NanoQ V2.5.9.0 Particle Size Analyzer. The particle sizes, reported in Table 5, 
are much larger than the zinc oxide precursor of 10-30 nm, indicating high levels of 
agglomeration.  Agglomeration of nanoparticles decrease their overall surface area. The 
decreased surface area should result in lower overall reactivity. Since agglomeration was 
observed across the nanoparticles of all silver loadings, the effect of the agglomeration did not 
affect the observations of this study. 
Table 5: The measured average particle size of zinc oxide nanoparticles with various 
silver loadings, as reported by the NanoQ V2.5.9.0 Particle Size Analyzer. 
Molar Percentage Average Particle Size (nm) Standard Deviation (%) 
1 894.97 94.37 
3 505.19 37.92 
100 1926.44 142.57 
14000 492.99 51.16 
42000 595.20 63.68 
1400000 587.67 56.12 
 
3.4 Discussion 
As expected, an improved photocatalytic reaction rate was found with increasing silver 
loading. However, significant improvement, when compared to pure zinc oxide, was not 
found until a silver loading of 700,000%. Previous studies found immediate improvement 
with silver loading, though it was not stated at which point the improvement became 
significant (Zhang and Mu, 2007; Yildirim, Unalan and Durucan, 2013). This difference could 
be due to the different synthesis methods, or the different nanoparticle morphologies.  
While the study completed in this thesis found improvement in hydroxyl production 




loading, other studies found an optimal silver loading, after which photocatalytic activity 
decreased. The optimal loading was found to be 6.2 wt.% (85,709 molar %) for the nanorod-
like morphology (Zhang and Mu, 2007). Studies have attributed the decrease in photocatalytic 
activity to be due to the blocking of  adsorption sites available by the metal (Jiang et al., 
2014). It is possible that the decrease in adsorption sites may be experienced by higher silver 
loadings not observed in the current study. 
The plateau of photocatalytic improvement experienced in this study is consistent with 
(Yildirim, Unalan and Durucan, 2013), though they noticed that the decrease in conversion 
rate improvement was experienced at higher silver loadings. The synthesis method used by 
Yildirim et al. (2013) found a decrease in overall particle size associated with higher silver 
loading ratios. This decrease in particle size increased the availability of adsorption sites and 
oxygen defects (Yildirim, Unalan and Durucan, 2013). The work completed in the current 
study did not observe significant changes in particle size with silver loadings. The 
photocatalytic improvement therefore may not be attributed to a decrease in particle size.   
Characterization of the nanoparticles found that the change in adsorption bandgap was 
minimal. The benefits of plasmonic photocatalysis is typically classified by two mechanisms, 
LSPR and Schottky junctions (Zhang et al., 2013). The lack of a change in the bandgap 
indicates that the improved photocatalytic activity in this case may not be due to LSPR 
effects. In addition, it has been demonstrated that LSPR effects may decrease with Schottky 
effects, and the LSPR effects decrease with increased silver loading (Jiang et al., 2014). The 
increased conversion rate can, therefore, be attributed to the increased electron-hole separation 
provided by the metal: metal-oxide semiconductor junction (Zhang et al., 2013). The better 
separation leads to the higher production of reactive oxygen species. The metal component 
can be referred to as an electron sink (Bensalah et al., 2014). This leaves the holes to freely 
interact with water on the surface of the metal oxide, creating hydroxyl radicals, which are 
responsible for the conversion of TPA into HTPA.  
Both SEM imaging and particle size analysis found high levels of agglomeration. An 




the levels of available adsorption sites. Since adsorption is a crucial step for photocatalytic 
degradation (Turchi and Ollis, 1990), agglomeration would best be avoided.  The high 
agglomeration was consistent throughout all molar percentages of silver tests. 
The nanoparticles hydrothermally synthesized with a zinc oxide nanoparticle seed 
resulted in a consistent sphere-like morphology. Studies that synthesized the silver-zinc oxide 
nanoparticles in a single step found a rod-like morphology (Zhang and Mu, 2007), due to the 
preferential growth of zinc oxide along the [0001] crystallographic face (Mclaren et al., 2009). 
The differences in photocatalytic activity are possibly caused by the difference in 
photocatalyst shape.  
The significant improvement of hydroxyl production found with high silver loading 
implies that the use of plasmonic photocatalysis has potential for improved contaminant 
removal. The metal: metal oxide junction created a Schottky barrier, which causes charge 
carrier separation, enhancing hydroxyl production.  
3.5 Chapter Summary 
The use of plasmonic photocatalysis for improved photocatalytic activity was studied 
in this chapter. Zinc oxide nanoparticles were loaded with a range of silver to identify the 
optimal ratio of metal: metal oxide. Hydrothermal synthesis provides a simple method for 
nanoparticle functionalization that may possibly be applied at an industrial manufacturing 
scale in the future. Photocatalytic activity was measured under UV light irradiation to convert 
TPA into HTPA. A zero-order reaction model was used to identify the conversion rate 
constants. There was a significant improvement in the conversion rate constant beginning at a 
mass percentage of 5.06% when compared to pure zinc oxide. Characterization of the 
synthesized nanoparticles found that the bandgap of the material did not greatly change with 
silver loading. The improvement in conversion rates can therefore be attributed to the 
increased charge carrier separation effects created by the Schottky junction. SEM imaging and 
particle size analysis demonstrated high agglomeration of the nanoparticles in solution, which 




morphology throughout all silver loading ratios. Overall, functionalization of zinc oxide 
nanoparticles using plasmonic photocatalysis provides a significant improvement to hydroxyl 
production, indicating that it may be useful for improving contaminant removal in future 







Removal of Pharmaceuticals from Wastewater Effluent using 
Titanium Dioxide based Photocatalysis 
Photocatalysis has been widely considered, and accepted, as a potential method for the 
removal of emerging contaminants from wastewater and drinking water sources (Mirzaei et 
al., 2016). Photocatalysis is an advanced oxidation process that uses ultraviolet (UV) light and 
a photocatalyst to create the reactive oxygen species (ROS). The ROS then can react with 
contaminants to either degrade or convert them to less harmful substances. Titanium dioxide 
nanoparticles are commonly used for photocatalytic reactions as they are commercially 
available and have demonstrated high photocatalytic activity (Friedmann, Mendive and 
Bahnemann, 2010). 
Pharmaceuticals in wastewater effluent are of growing concern due to their potential 
effects on aquatic species and possibly human health. Examples of this are demonstrated by 
the effects that contaminants are having in fish populations.  Male fish were feminized, with 
oocytes (eggs) developing in their testes when exposed to municipal wastewater (Tetreault et 
al., 2011). Fish exposed to antidepressants show lethargic behavior and changes in their 
mating habits (Bisesi, Bridges and Klaine, 2014). The removal of pharmaceuticals from water 
and wastewater may therefore reduce the risks to both the environment and humans (e.g. 
drinking water).  
Past tests of pharmaceutical contaminant removal using photocatalysis often examined 
the pharmaceuticals in a pure water matrix. In this study, a cocktail of 24 pharmaceuticals was 
spiked into actual wastewater effluent, or a pure water matrix (Milli-Q). The prepared 
matrices were then tested for photocatalytic degradation using an in house photocatalytic 
testing setup. Two UV based removal tests were completed for each of the prepared samples, 
along with a control test, where no UV light was added. The first test used UV light irradiation 
to observe whether indirect or direct photolysis was enough to degrade the pharmaceuticals. 




photocatalytic removal. A comparison of removal efficiencies between a pure water matrix 
and wastewater effluent was then completed. Additional parameters were also considered for 
effects on photocatalytic removal including the electrostatic interactions between the catalyst 
and the contaminants and the degradation of natural organic matter (NOM) which was present 
in the wastewater effluent samples. 
4.1 Materials and Methods 
The materials and methods employed in this experiment involved numerous steps 
(Figure 4-1). First, a wastewater final effluent grab sample was collected August 14, 2018, 
from the Waterloo Regional Wastewater Treatment plant, following the protocol outlined in 
Appendix A4: Collection of Wastewater from Waterloo Wastewater Treatment Plant. 
Wastewater effluent was stored on ice and then filtered using a 2 µm filter (Whatman) to 
remove the large particulate matter. Wastewater effluent was tested within 48 hours of 
collection.  
 The wastewater effluent was then spiked from a stock solution composed of 24 
different chemicals (mostly pharmaceuticals, degradation products or wastewater related 
contaminants), to create a suspension of 2 µg/L of each pharmaceutical compound. These are 
typical concentrations much higher than found in final effluent (Arlos et al., 2015; Hicks et 
al., 2017). Degradation tests were completed in six conditions outlined in Table 6. Either 
wastewater effluent or pure Milli-Q water was used as the test solution, spiked with 
pharmaceutical cocktail. Tests referred to as UV disinfection contained UV light, but no 
photocatalyst (x.x.UV.B). Tests referred to as photocatalytic tests contained both UV light and 
the photocatalyst (x.x.UV.P25). The pharmaceuticals in methanol were first evaporated in the 
fume hood before the water solution was added. The UV 365 lamp was turned on for constant 
illumination at time zero if it was used. Additionally, 30 mg of P25 (titanium dioxide 













Table 6: Test conditions. Code: E= Effluent/ M= Milli-Q, U=Unspiked/ S= Spiked with 
Pharmaceutical Cocktail, UV= UVA Light Source/ D= Dark, P25= TiO2 Nanoparticles 
included/ B=Blank (no nanoparticles added). 
Plate Name Effluent Spiked Pharmaceutical UV Light? Nanoparticles? 
E/S/D/B ✔ ✔ ✖ ✖ 
     
E/S/UV/B ✔ ✔ ✔ ✖ 
     
E/S/UV/P25 ✔ ✔ ✔ ✔ 
     
M/S/D/P25 ✖ ✔ ✖ ✔ 
     
M/S/UV/B ✖ ✔ ✔ ✖ 
     
M/S/UV/P25 ✖ ✔ ✔ ✔ 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
4.1.1 Photocatalyst and Pharmaceuticals 
Titanium dioxide nanoparticles were purchased from Sigma-Aldrich. Pharmaceutical 
compounds were purchased from Sigma-Aldrich and suspended in methanol. Designated 
isotopically labelled standards were used for LC-MS/MS analysis and quantitation (except for 
monensin), and lorazepam was used as an internal standard. These standards were purchased 
from CDN Isotopes Inc. (Pointe-Claire, QC, Canada), except for atorvastatin-d5, which was 
purchased from Toronto Research Chemicals (Toronto, ON, Canada). The pharmaceutical 
compounds were dissolved in methanol as 1 g/L stock solutions in amber glass vials and 
stored at -20℃. The full list of pharmaceutical compounds and their dissociation constants and 




Table 7: Chemicals used in this study and some of their properties. All data was 






Acetaminophen C8-H9-N-O2 9.38 analgesic 
Atenolol C14-H22-N2-O3 9.6 beta-blocker 
Atorvastatin C33-H35-F-N2-O5 4.3, 14.9 lipid lowering 
Atrazine C8-H14-Cl-N5 1.6 herbicide 
Bisphenol A C15-H16-O2 9.6 plastic filler 
Caffeine C8-H10-N4-O2 14 beverage 
Carbamazepine C15-H12-N2-O 13.9 anti-epileptic 
Desvenlafaxine C16-H25-N-O2 9.45, 10.66 anti-depressant 
Diclofenac C14-H11-Cl2-NO2 4.15 anti-inflammatory 
Carbamazepine- 
10,11-Epoxide 
C15-H12-N2-O 13.9 carbamazepine 
degradation product 
Fluoxetine C17-H18-F3-N-O 9.8 SSRI (anti-depressant) 
Gemfibrozil C15-H22-O3 4.5 lipid lowering 
Ibuprofen C13-H18-O2 5.2, 4.91 anti-inflammatory 
Lincomycin C18-H34-N2-O6-S 7.6 antibacterial 
Monensin C36-H62-O11 4.2 antibiotic 
Naproxen C14-H14-O3 4.15 anti- inflammatory 
Norfluoxetine C16-H18-F-N3-O3 6.34, 8.75 Fluoxetine degradation 
product 
o-Atorvastatin C33-H35-F-N2-O5 4.3, 14.9 Atorvastatin 
degradation product  
p-Atorvastatin C33-H35-F-N2-O5 4.3, 14.9 Atorvastatin 
degradation product  
Sulfamethoxazole C10-H11-N3-O3-S 1.6, 5.7 antibiotic 
Sulfanilamide C6-H8-N2-O2-S 10.43 antibacterial 
Triclosan C12-H7-Cl3-O2 7.9 antimicrobial 
Trimethoprim C14-H18-N4-O3 7.12 antimicrobial 




4.1.2 Photocatalytic Setup 
The photocatalytic setup may be found in Figure 3-2. Aliquots of 300 mL of spiked 
solution (wastewater or Milli-Q) were placed in beakers on a stir plate set to 600 rpm. The stir 
plate was placed below the in-house assembled six-cm collimated UV-LED beam (θbeam= 4 
cm) light source setup with a heat sink. The light sources were 10.5 cm above the surface of 
the water. The samples were stirred for 60 minutes before the light source was turned on. 
Samples were taken in 4.5 mL aliquots at -60, 0, 5, 10, 20, 40, 60, 90, 120 minutes. pH of the 
solutions was measured before and after the photocatalytic tests. 
 
Figure 4-2: Photocatalytic degradation setup. 
4.1.3 Solid Phase Extraction and LCMS 
Samples were centrifuged at 3500 rpm to remove the particulate matter. Four mL of 
the samples were then transferred to new glass tubes, where they were spiked with 32 µL of 
100 ug/L deuterated pharmaceutical standards. Solid phase extraction (SPE) was completed 




detailed SPE procedure can be found in Appendix A6: Solid Phase Extraction of 
Pharmaceuticals.  
After extraction, the samples were evaporated using the Thermo Scientific™ Rocket 
Synergy™ Evaporator System. The dried samples were then resuspended in 160 µL of 
reconstitution solution, composed of methanol containing lorazepam and chloramphenicol (75 
μg/L). The samples were then stored in a -20℃ freezer until Liquid Chromatography-Mass 
Spectroscopy analysis. The liquid chromatography and tandem mass spectrometry (LC-
MS/MS) was completed using an Agilent 1200 HPLC coupled to an Applied Biosystems 3200 
QTRAP mass spectrometer (ABSciex, Concord, ON, Canada). 
4.1.4 Data Analysis  
Data processing was completed using Excel, and a first order linear conversion model, 
Equation 3-1, matched the degradation patterns of the pharmaceutical. [A] represents the 
concentration of the pharmaceutical, [A0] represents the initial concentration, and k is the first 
order conversion rate constant (1/min).  
𝐥𝐧[𝑨] = −𝒌𝒕 + 𝐥𝐧[𝑨𝟎] Equation 3-1 
The linest function in Excel was used to find the linear model of fit. The F-statistic was 
used to determine whether the null hypothesis that the values are just a random scatter of 
points with a slope of zero was correct. Where the null hypothesis passed, the k values were 
changed to zero for further comparisons. Similarly, if a positive slope was calculated- 
suggesting formation of pharmaceuticals, the k value was also changed to zero.  Further 
statistical analysis was completed using SigmaPlot software (Systat Software, San Jose, CA). 
An ANOVA was completed to determine whether the charges of the pharmaceutical in 




4.1.5 Water Quality 
Samples were sent to Maxxam analytics for a before and after analysis of total organic 
carbon. Measurements were also completed to measure the initial organics amount, including 
total ammonia, conductivity, dissolved chloride, nitrite, nitrate, and nitrate + nitrite. 
4.2 Results 
4.2.1 Pharmaceutical Degradation 
Successful pharmaceutical degradation was achieved using photocatalysis in both 
Milli-Q and wastewater. In some scenarios, pharmaceutical removal to below the detection 
limit was achieved in as little as five minutes. In every case, even if full pharmaceutical 
removal was not achieved, partial degradation occurred. Additionally, some decrease in the 
TOC occurred when photocatalysis was applied to the wastewater effluent.  
The degradation tests resulted in 2 patterns. The first, and most dominant pattern, is 
exemplified by ibuprofen, where only photocatalysis successfully degrades the 
pharmaceutical. Figure 4-3 and Figure 4-4 plots the ln(concentration) of the pharmaceutical 
against the time the solution was exposed to the degradation test. In the Milli-Q suspension, 
the photocatalytic reaction fully removed ibuprofen in an average of 20 minutes, with a 
reaction rate constant of 0.3878 1/min. UV alone (M/S/UV/B) provided a small amount of 
removal with a much lower removal rate of 0.0033 1/min. The blank control showed no 
removal (removal rate of 0). In wastewater effluent, the photocatalysis test (E/S/UV/P25) 
with ibuprofen had a much lower removal rate of 0.01136 1/min (Figure 4-4). UV 
disinfection and a blank test in the effluent resulted in no significant removal. Most of the 
other chemicals followed a case similar to this, where UV disinfection had a removal rate in 
Milli-Q (M/S/UV/B) of less than or equal to 0.01 1/min were  acetaminophen, atenolol, 
atrazine, bisphenol-a, caffeine, carbamazepine, carbamazepine- 10,11-epoxide, 




sulfonamide, triclosan, trimethoprim, and venlafaxine. The degradation plots are in 
Appendix C1: Degradation Plots.  
 
 
Figure 4-3: Ibuprofen degradation in pure (Milli-Q) water. This is the first category of 
degradation, where only photocatalysis successfully degrades the pharmaceutical. The 
purple dots represent the dark study with P25, the blue indicates just UV irradiation, 































Figure 4-4: Ibuprofen degradation in wastewater effluent. Photocatalysis has little effect 
on pharmaceutical removal. The blue represents the dark study, red represents UV 
irradiation and green represents photocatalytic degradation. 
The second pattern of degradation is demonstrated by monensin (Figure 3-5), where UV 
disinfection can partially degrade the pharmaceutical. In the pure water suspension, 
photocatalysis (E/S/UV/P25) achieved complete removal of the pharmaceutical in 40 min. In 
wastewater effluent, UV disinfection failed to remove monensin as demonstrated by Figure 3-
6. In this case, photocatalysis is only marginally successful in wastewater effluent. The other 
pharmaceuticals that follow a degradation like monensin are atorvastatin, diclofenac, 































Figure 4-5: Degradation of monensin in pure (Milli-Q) water. The use of UV disinfection 
removes some of the pharmaceutical, and the addition of photocatalysts greatly 
improved the removal.
























































unsuccessful at removing the pharmaceutical, and the addition of photocatalyst is only 
partially successful. 
The degradation rate constants for all pharmaceuticals tested are reported in Table 8 
and Table 9 below. A degradation rate of zero indicates that no significant removal occurred. 
This was common in the pure water, dark matrix with P25. As stated earlier, UV irradiation 
removed some of the pharmaceutical contaminants. However, the removal rates were often 
low (less than or equal to 0.01 1/min). The addition of the photocatalyst resulted in 
improvement of the pharmaceutical removal rate. When added to wastewater effluent, the 
removal rate was decreased compared to the Milli-Q water. This exemplifies the effects that 
natural organic matter has on the reactive oxygen species (scavenging and blocking light). In 
cases where UV irradiation was effective in the Milli-Q matrix, it did not always result in 
significant removal in wastewater effluent and rates were usually much reduced (Table 8, 9).  
Table 8: Degradation rate constants (1/min) and the sum of residual squares of 
chemicals spiked in pure (Milli-Q) water for a first-order reaction model. 
Sample Name M/S/D/P25 M/S/UV/B M/S/UV/P25  
k (1/min) r^2 k (1/min) r^2 k (1/min) r^2 
Acetaminophen 0 0.3502 0.0071 0.9882 - - 
Atenolol 0 0.2670 0.0048 0.9508 0.0516 0.9399 
Atorvastatin 0.0048 0.9300 0.0188 0.9067 1.4090 1.0000 
Atrazine 0 0.3384 0.0024 0.9536 0.0362 0.9866 
BisphenolA 0 0.0321 0.0073 0.9891 1.4668 1.0000 
Caffeine 0 0.0543 0 0.4429 0 0.2724 
Carbamazepine 0 0.0222 0.0043 0.9768 0.0314 0.5376 
Carbamazepine- 
10,11-Epoxide 
0 0.2052 0.0030 0.9111 0.0410 0.7409 
Desvenlafaxine 0 0.8687 0.0060 0.9966 - - 
Diclofenac 0 0.1058 0.0138 0.9965 1.4506 1.0000 
Flouxitine 0 0.1972 0.0185 0.9788 0.0339 0.6870 
Gemfibrozil 0 0.0293 0.0066 0.9364 - - 
Ibuprofen 0 0.3546 0.0033 0.7630 0.3878 0.9142 
Lincomycin 0 0.0423 0.0084 0.9920 0 0.2856 




Sample Name M/S/D/P25 M/S/UV/B M/S/UV/P25  
k (1/min) r^2 k (1/min) r^2 k (1/min) r^2 
Naproxen 0 0.3020 0.0076 0.9427 1.1358 1.0000 
Norfluoxetine 0.0018 0.5244 0.0194 0.9900 0.0321 0.7403 
O-Atorvastatin 0.0145 0.8708 0.0240 0.8807 - - 
P-Atorvastatin 0.0111 0.9697 0.0231 0.9488 - - 
Sulfamethoxazole 0 0.0031 0.0066 0.9724 - - 
Sulfonamide 0 0.9178 0.0030 0.9383 - - 
Triclosan 0 0.0526 0.0094 0.9930 0.7728 0.9843 
Trimethoprim 0 0.6471 0.0091 0.9950 0.0398 0.7475 
Venlafaxine 0 0.6461 0.0080 0.9959 0.0454 0.7025 
 
 
Table 9: The first order reaction rate constant (k 1/min) and the sum of residual squares 
for the first order model of fit for chemicals spiked in wastewater effluent. 









R2 k (1/min) R2 k (1/min) R2 
Acetaminophen 0 0.28079 0 0.29472 - - 
Atenolol 0 0.08929 0 0.46614 0.01074 0.96091 
Atorvastatin 0.00136 0.64663 0.01409 0.90040 0.05221 0.99380 
Atrazine 0 0.25630 0.00176 0.32227 0.00303 0.80900 
BisphenolA 0 0.02387 0.00329 0.68440 0.02963 0.96430 
Caffeine 0.00206 0.54929 0 0.01589 0.00967 0.87181 
Carbamazepine 0 0.00125 0.00252 0.59832 0.01612 0.98643 
Carbamazepine- 
10,11-Epoxide 
0 0.00104 0 0.40973 0.01153 0.96796 
Desvenlafaxine 0 0.85351 0 0.00564 0.03262 0.96834 
Diclofenac 0 0.00549 0.00547 0.90284 0.01843 0.78928 
Flouxitine 0 0.00347 0 0.26222 0.01373 0.95452 
Gemfibrozil 0 0.25208 0.00324 0.51081 0.01254 0.94680 
Ibuprofen 0 0.01345 0 0.24262 0.01136 0.95101 
Lincomycin 0 0.26061 0.00364 0.74359 0.05254 0.99209 
Monensin 0 0.68527 0.00356 0.64608 0.01758 0.95568 
Naproxen 0 0.02718 0.00586 0.74839 0.03916 0.96021 













R2 k (1/min) R2 k (1/min) R2 
O-Atorvastatin 0.00076 0.57093 0.01748 0.95939 0.04987 0.79231 
P-Atorvastatin 0 0.33649 0.01512 0.94916 - - 
Sulfamethoxazole 0 0.23577 0.00368 0.66885 0.03694 0.97880 
Sulfonamide 0 0.44365 - - 0.02523 0.98919 
Triclosan 0 0.00063 0.00305 0.58206 0.03438 0.90501 
Trimethoprim 0 0.31292 0 0.40545 0.01382 0.97954 
Venlafaxine 0 0.59528 0.00021 0.01916 0.01212 0.95918 
 
In some cases, full degradation (below the analytical detection limits) of the 
pharmaceutical was achieved within the testing time. Table 10 reports the time for full 
removal of the pharmaceutical in Milli-Q and in effluent, where it occurred. Removal as fast 
as five minutes occurred in four pharmaceuticals in Milli-Q (atorvastatin, bisphenol a, 
diclofenac, p-atorvastatin), and the fastest removal occurred in effluent in forty minutes, for 
sulfonamide.  
Table 10: Time for full removal of pharmaceuticals (below detection limit), when it 
occurred. N/A indicates full removal did not occur.  
Chemical Milli-Q time for 
full removal (min) 
Effluent time for 
full removal (min) 
Acetaminophen 60 90 
Atenolol N/A N/A 
Atorvastatin 5 N/A 
Atrazine N/A N/A 
Bisphenol A 5 N/A 
Caffeine 60 N/A 




Desvenlafaxine 120 N/A 




Chemical Milli-Q time for 
full removal (min) 
Effluent time for 
full removal (min) 
Fluoxetine N/A N/A 
Gemfibrozil 120 N/A 
Ibuprofen 20 N/A 
Lincomycin N/A N/A 
Monensin 40 N/A 
Naproxen 20 N/A 
Norfluoxetine N/A N/A 
o-Atorvastatin N/A N/A 
p-Atorvastatin 5 60 
Sulfamethoxazole 20 N/A 
Sulfanilamide 10 40 
Triclosan 10 N/A 
Trimethoprim N/A N/A 
Venlafaxine N/A N/A 
 
4.2.2 Degradation Rates and Chemical Charge 
A Brown-Forsythe and Tukey test (ANOVA) completed found statistical significance 
between the conversion rates of the negative charged pharmaceuticals and both the positive 
and neutral pharmaceuticals. There was no significance between the neutral and positively 
charged pharmaceuticals. In wastewater effluent, there was no significant differences between 





Figure 4-7: The conversion rate constants of pharmaceuticals in Milli-Q water (pH ~ 5) 
organized based on their charge at that pH. 
 
Figure 4-8: The degradation rate constants for pharmaceuticals in wastewater effluent 




4.2.3 Water Quality 
The total organic carbon (TOC) was measured upon collection from the Waterloo 
wastewater treatment plant, and after pharmaceutical degradation tests were performed (Table 
11, 12). The TOC values and overall percent changes are reported in Table 12. Some natural 
degradation of TOC occurred in the blank test (7% removal), and UV disinfection added 
around 5% removal. The photocatalytic test resulted in a 26% removal of TOC. This suggests 
that the decrease in photocatalytic degradation rates in the wastewater effluent samples can be 
due to the scavenging of the generated ROS by the organic matter in the solution.  









Total Ammonia mg/L 0.050 1.37 0.047 
Conductivity umho/cm 1.0 2400.00 0.000 
Total Organic 
Carbon (TOC) 
mg/L 0.50 9.37 0.205 
Dissolved 
Chloride 
mg/L 6.0 490.00 8.165 
Nitrite mg/L 0.010 0.53 0.009 
Nitrate mg/L 0.50 36.53 0.170 
Nitrate + Nitrite mg/L 0.50 37.07 0.189 
 
Table 12: Total organic carbon for wastewater effluent upon collection from the 
Waterloo treatment plant and after photocatalytic tests were performed on the matrix. 
Inorganics Units Waterloo Treatment 
Plant 






mg/L 9.37 8.70 8.20 6.90 
  
Percent Change -7.12 -12.46 -26.33 
4.2.4 Change in pH 
Table 13 reports the pH of the test solutions, and their overall change after degradation 
tests. Note that the pH was measured before nanoparticles were added and after the 
nanoparticles were centrifuged out of the final solution. Overall, little change in pH was 
observed. 
Table 13: Average pH values measured for the water testing conditions. Insignificant 
















7.260 7.382 7.234 5.704 5.767 5.969 
Average 
Change 




0.017 0.085 0.055 0.152 0.082 0.065 
 
4.3 Discussion 
The removal of pharmaceuticals was much more effective in pure water than in a 
wastewater effluent matrix. While some organic compounds can assist in indirect photolysis, 
the presence of organics decreased the ability of the photocatalyst to remove all the 
compounds. This can be due to the scavenging of the reactive oxygen species and the 
scattering and absorption of UV light by inorganic carbons. Doll and Frimmel (2005) attribute 
the decrease in photocatalytic activity in NOM to be caused by the competitive adsorption of 




research completed indicates that small loading ratios of NOM (400 µg/g) can enhance the 
photocatalytic activity by up to 8%, by providing higher adsorption of reactants to the 
photocatalyst surface and serving as a photocatalytic intermediate. Higher loadings (400 
mg/g) resulted in the blockage of pharmaceuticals from reaching the TiO2 catalyst (Drosos, 
Ren and Frimmel, 2015). The initial TOC of 9.37 mg/L indicates an initial ratio of TOC to 
P25 of 104 mg/g. The general decrease in photocatalytic removal of chemicals (e.g. 
pharmaceuticals) reported in the literature is consistent with this study. Although NOM may 
produce some indirect opportunity for photolytic degradation, scavenging effects of the 
organic matter in wastewater greatly reduced the over photocatalysis of the chemicals of 
interest. 
A decrease in total organic carbon was found when degradation tests were performed. 
There was a decrease of around 12% in the TOC with UV light irradiation (relative to 
controls) and over 25% in the TOC measurement after photocatalysis was applied to the 
matrix. This supports the conclusion that organic matter had a scavenging effect on both the 
formed reactive oxygen species and the UV light. A 50% mineralization of organic matter to 
carbon dioxide and water was reported by Eggins et al. (1997) in there experiments  after one 
hour  a mercury lamp (Eggins, Palmer and Byrne, 1997). 
Dark studies of the chemicals of interest in this study did not result in significant 
removal. In the dark Milli-Q water study with photocatalyst added most pharmaceuticals 
experienced no removal, but removal rates of 0.111 (1/min) and lower were found for 
atorvastatin, monensin, o-atorvastatin, p-atorvastatin and norfluoxetine. Interestingly, all these 
compounds were negatively charged in solution except for norfluoxetine. This demonstrates 
some removal associated with sorption in a pure water matrix, either to the glass or the 
photocatalyst. In wastewater effluent without UV irradiation or photocatalysts, atorvastatin 
and o-atorvastatin and caffeine demonstrated degradation rates (less than 0.002 1/min), 
indicating some adsorption of these compounds to the NOM and/or experimental apparatus 
(e.g. glass). The sorption levels potentially changed with the difference in pH between Milli-Q 




(2014), although they did not study any of the pharmaceuticals where this was observed in the 
current study. The likelihood of chemical  sorption to organic matter can be  predicted using 
the octanol- water partition coefficient based on equilibrium partitioning of the neutral 
chemical form, (Cheytt et al., 2005) although adsorption may also occur through charge 
interactions. As the pH differed in the two experimental conditions (Milli-Q and wastewater) 
some difference among the chemicals may be related to the dissociation constants (pKa) and 
therefore the partitioning to the organic matter making them less available for chemical 
reactions.  
Pure light irradiation by UV A LEDs did cause some removal of pharmaceutical 
compounds, as discussed in the results as the second case of removal. The low rates of 
removal by UV irradiation removal are consistent with the findings by Bielak et al. (2015), 
who found a much higher removal when UV light was combined with hydrogen peroxide, 
which served as a ROS donor (Bielak et al., 2016). The removal by light irradiation indicates 
that these pharmaceutical compounds may not persist as long in the environment, as they may 
be degraded by sunlight (Santoke and Cooper, 2017). The use of a UV C light source would 
likely improve this UV light removal (direct photolysis), as was found by (Choi et al., 2014). 
However, there was significant improvement in contaminant removal when a photocatalyst 
was added in the current study.   
More oppositely charged particles have a higher chance of electrostatic interaction 
(Kumar, 2017). The point of zero charge of P25 has been established at a pH of 7.5 
(Fernández-Nieves, de las Nieves and Richter, 1998). The P25 photocatalyst is therefore 
slightly positive in wastewater effluent, at a pH of 7, and even more positive in pure water at a 
pH of 5. It is therefore presumed that pharmaceuticals that exhibit a negative charge in 
solution will have a higher degradation rate constant due to electrostatic attraction to the 
photocatalysis (Arlos, Hatat-Fraile, et al., 2016; Arlos, Liang, et al., 2016). The increased 
attraction would increase the chance of adsorption, which is a crucial step for photocatalysis 
(Turchi and Ollis, 1990). The decrease in conversion rate observed in this test was 




sample. This effect was not significant in a wastewater effluent sample, where NOM appears 
to influence the degradation patterns. 
4.4 Chapter Summary 
The photocatalytic removal of pharmaceutical compounds in both a pure water 
suspension and a wastewater effluent matrix was studied. The effects of NOM, the charges of 
the pharmaceuticals in solution and the addition of a photocatalyst to UV light irradiation was 
observed. Overall, photocatalysis was demonstrated to successfully remove several 
pharmaceutical compounds to below the detection limit. The improvement of photocatalysis 
over UV irradiation was evident. UV disinfection was at times successful in removing some of 
the pharmaceutical, but never resulted in full removal (below analytical detection limits). In 
contrast, the wastewater effluent had a decrease in total organic carbon after photocatalytic 
tests, indicating scavenging of the UV light by organic compounds in the solution. This 
resulted in much reduced rates of removal of the pharmaceuticals. In a pure water matrix, 
many pharmaceuticals were photocatalytically degraded in as little as five minutes, 
demonstrating feasibility of municipal treatment scale. However, in the wastewater matrix, 
full removal was rarely observed. This is consistent with other studies that spiked 
pharmaceuticals in a wastewater effluent sample (Choi et al., 2014). The slow reaction 
constants for contaminant removal in wastewater will remain a challenge for the application of 
photocatalysis treatment, especial in the presence of high levels of organic matter and where a 







Conclusions and Recommendations 
The objectives of this research were to explore the use of photocatalysts in water 
treatment applications. A large barrier in photocatalyst applications is the low efficiency of 
hydroxyl production. Functionalization of the nanoparticle with a metal was tested to improve 
photocatalytic efficiency through plasmonic photocatalysis. Photocatalytic tests of 
pharmaceutical removal are also typically completed in a pure water matrix that is not 
representative of surface waters or effluents. Photocatalytic removal of 24 different chemicals 
(mostly pharmaceuticals) was tested using both pure water and wastewater effluent collected 
from a local water treatment plant (Waterloo). Although photocatalysts (P25) can successfully 
remove emerging contaminants from water, wastewater still represents a major challenge. 
Functionalization of nanoparticles can greatly improve the photocatalytic efficiency and hold 
promise for future treatment applications.   
In Chapter 2 it was found that an increased silver content resulted in a significant 
improvement in the photocatalytic efficiency of zinc oxide nanoparticles. The improvement is 
attributed to the improved electron-hole separation provided by the metal: metal-oxide 
junction in plasmonic photocatalysts. While previous studies have used plasmonic 
photocatalysis, few have considered the optimal ratio of metal: metal-oxide. The study 
completed in this thesis found significantly increased hydroxyl formation when higher silver 
ratios were used. Significant improvement over pure zinc oxide nanomaterials consistently 
began at a mass percentage of 5.06%. A different study found the same pattern of significant 
improvement to a certain degree of silver loading. This contrasts with another previous study, 
where an optimal photocatalytic efficiency was found and decreased with increasing molar 
ratios. The difference in optimal silver loading between that study and one completed in this 
thesis may be due to different nanoparticle morphology. The hydrothermal synthesis method 
that used a seed of zinc oxide nanoparticles maintained a sphere like morphology after 




promising for large scale synthesis operations. High agglomeration occurred for all molar 
percentages, meaning it may have had little effect on the efficiencies of hydroxyl formation. 
Additionally, no discernable change in bandgap occurred for the different silver loadings, 
indicating that the light adsorption properties of the nanomaterial were unchanged with silver 
loading. 
Chapter 3 tested the photocatalytic removal of pharmaceuticals from both wastewater 
effluent and a pure (Milli-Q) water matrix. Photocatalysis greatly improved the removal of 
pharmaceuticals from the Milli-Q water matrix, when compared to just UV light irradiation. 
However, when applied in wastewater effluent, the photocatalysis became less active. This is 
likely due to the scavenging of reactive oxygen species and the scavenging of and shielding of 
UV light caused by the organic compounds, as demonstrated by the high decrease in total 
organic carbon. This is a clear demonstration of why a large barrier exists between research 
regarding photocatalysis and commercialization of photocatalytic water treatment systems. 
UV irradiation had some effect on contaminant removal, but the removal rates were often 
much lower than with the addition of the photocatalyst. This demonstrates the potential value 
in adding a photocatalyst to the UV water treatment setup. Additionally, it is also presumed 
that a contaminant more oppositely charged to the catalyst will have higher electrostatic 
interaction. The higher interactions should result in an increased photocatalytic removal. The 
charge of the photocatalyst was positive in the solutions studied and it was found that the 
charge of the pharmaceutical in solution had some effect on its removal. However, other 
properties of the pharmaceutical, including solubility may also have a large effect, especially 
in natural waters containing NOM. The high decrease in photocatalytic efficiency when 
completed in representative wastewater effluent relative to pure (Milli-Q) water demonstrates 
the need for laboratory testing to be completed using representative water matrices.   
Future research in photocatalytic testing should consider commercialization at the 
beginning of the experimental design phase. The barriers associated with the marketing of 
photocatalytic water treatment are still vast but include the need to remove nanomaterials after 




removal of pharmaceuticals reported in this thesis and the environmental pressures imposed 
by emerging contaminants on the environment provide high motivation to continue research in 
photocatalytic water treatment.  
Continuation of this research may involve fine-tuning of hydrothermal synthesis 
methods of plasmonic photocatalysts to continue optimization of efficiency. One must aim for 
simple synthesis methods for easier commercial production. Removal of the nanomaterials 
continues to be a challenge, and future researchers may consider the exploration of core-shell 
magnetic photocatalysts to create photocatalysts that may be removed by applying an electric 
field to the solution, or immobilization and filtering methods that do not result in a 
considerable loss in efficiency. The optimally manufactured plasmonic photocatalyst may also 
be tested in the removal of the emerging contaminants, such as pharmaceuticals, to confirm 
that the improved hydroxyl formation results in improved contaminant removal. An ideal 
photocatalytic setup would consider a specific contaminant that must be removed 
Alternatively, one may group contaminants by physical properties that indicate they may have 
similar mechanisms for removal. Charge of the contaminant and photocatalyst may be a 
strong consideration, as demonstrated by the improved degradation rate constants by 
electrostatic attraction. Alteration in pH may be explored to improve removal or target 
analytes. 
There is also a challenge regarding the degradation byproducts. Some of the 
intermediates of pharmaceutical degradation are more harmful than the initial contaminant. 
Enhancement of analysis methods by inclusion of additional degradation intermediates may 
provide insight into whether the contaminant is fully mineralized, rather than just removed. 
This consideration may be made for pharmaceuticals as well as other emerging contaminants.  
While vast improvements have been made in photocatalytic water treatment over the 
past forty years of research, there still exists ample opportunities to improve water treatment 
methods to ensure sustainable water sources. The need for novel treatment approaches will 
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Appendix A: Standard Operating Procedures 
This appendix outlines the standard operating procedures that were used for the work 
completed in this thesis. The procedures include those for Chapter 2 including photocatalytic 
activity (the TPA test), the synthesis methods used for the plasmonic photocatalysts, and the 
measurement of the bandgap. The remainder of this section refer to the protocols used in 
Chapter 3, including the collection of wastewaters, the pharmaceutical degradation test and 
the solid phase extraction of the pharmaceuticals.  
A1: TPA to HTPA Conversion Protocol 
1. Make 1L of TPA Solution: 0.0831 g TPA (sigma) dissolved in 6 mL of 1 M NaOH in 
a volumetric flask, then filled to the 1 L mark with Milli-Q water. Sonicate 10 
minutes. 
2. Prepare beaker solutions accordingly: add 30mg of powder to each beaker, use 
thinnest beakers available for better sonication 
3. Sonicate Beaker powdered solutions (without stir bar) for 5 minutes 
4. Calibrate the pH meter and measure pH 
5. Measure the Power output of each individual light 
6. Program: PM100/200 Utility 
7. Press Meas Config>Zero Adjust>Cover Sensor 
8. Press Log Config> Select Log File: Save to folder Ivana as a .txt with the default 
name plus '_2_Uvx' (2 is for setup 2, x is light one two or three) 
9. Turn on each lamp individually, place sensor in middle of light and press 'Start Log' 
10. Once complete (dates will appear instead of sample #s along bottom of display plot) 
press export data and select the log file you made, press okay 
11. Switch UV lights, press reset/clear, then 'Start Log' 
12. Once complete, 'export data' and save with same name as UV1, just change UV#. 
13. Repeat for UV 3 
14. With beakers under foil, stir samples for 60 minutes in the dark 
15. Turn on the UV light at T=0. 
16. Take 1mL samples of each beaker into micro centrifuge tubes at T= -60, 0, 1, 5, 10, 
20, 40, 60, 90, 120, 180, 240, 300 min 




18. Make standards of HTPA from 60 uM stock solution for the standard curve. Make a 
serial dilution. 
 
Table A 1: Serial dilution of HTPA calibration curve. 
C (uM) Volume of the Higher Concentration 
(mL) 
Volume of Water/ solution 
(mL) 
20 0.333 0.667 
10 0.5 0.5 
6 0.6 0.4 
2 0.333 0.667 
1 0.5 0.5 
0.5 0.5 0.5 
0.25 0.5 0.5 
0.1 0.4 0.6 
19. For the blank, mix 2uL of 1 M NaOH in 998 uL of Water/ solution 
20. Centrifuge the samples at 1600g and 24 degrees Celsius (default temperature) for 10 
minutes to remove the TiO2, P25, and other particles 
21. Add 300 uL of each samples and the stock to a black plate, record the chosen layout 
22. Use the plate reader at the following settings: 
a. Fluorescence Spectrum 
b. Excitation: 315 nm 
c. Range: 350 nm- 55 0nm 
d. Step Size: 1 
e. No cutoff 
f. Shake 5 Seconds before 1st read 
g. 6 flashes per second, auto gain 






A2: Hydrothermal Synthesis 
1. Add 1 g P25 into 125 mL acid digester containing 60 mL of Acid Digester 
2. For the acid digester, measure out 60mL of Milli-Q and add the appropriate amount 
of Silver Nitrate and HMTA  
a. AgNO3 (1 mM – 10.2 mg) and HMTA (2 mM – 16.8 mg).  
3. Heat acid digester to 100°C for 4h in a pressurized vessel. 
4. Ag ions in solution were removed by washing with ultrapure water, centrifuging 
samples, and decanting the supernatant 
a. First from the oven, remove the contents into a 400 ml beaker, rinsing the 
containers with Milli-Q and placing in the beaker until there are no traces 
left  (2-3 rinses with squirt bottle). 
b. Next leave that beaker to stir for about 5 minutes 
c. Aliquot about 25 mL of the solution into eight separate 50ml conical tubes. 
Continue adding to each tube bit by bit until the beaker is empty. Rinse the 
beaker and add to 50 mL conical tubes  
d. My centrifuge process is 3500 rpm. Complete three cycles. The first Is 30 
minutes, followed by 20 then 10 minutes. 
5. In between cycles, dump the supernatant into the waste, refill the tubes with Milli-Q 
and resuspend the pellet (vortex in at 3000 for 15 seconds does most of the trick, add 
some manual shaking to complete if necessary) 
6. After the last cycle, dump out supernatant and resuspend only in about 25 ml Milli-Q. 
The dump all tubes into a single beaker and rinse tubes with Milli-Q also dumping 
into beaker. We then perform suction filtration, rinsing with ethanol three times. 
Ensure you get all of the particles from the beaker. 
7. After Suction filtration, Dry the Ag solution (can leave on filter paper at 80°C for 8 h 
(or overnight). 
8. Weigh and label a glass scintillation vial 
9. Once particles are dried overnight, scrape them into the labelled scintillation vial 
10. Mass yield= Mass With Particles- Mass Empty Vial 






A3: UV- Diffuse Reflectance Spectroscopy 
Samples are prepared by sonicating a small about (about 2 mg) in ethanol. The 
samples were then filtered through 2 µm filter paper. The filter paper was dried in the oven 
overnight.  
The DRS spectra was collected using a Shimadzu UV-2501PC UV-Visible-NIR 
spectrophotometer equipped with an integrating sphere accessory, using N2(g) as the reference. 
The bandgap was calculated using the following equations (López and Gómez, 2012): 
R is the measured reflectance, and 𝛼(ℎ𝑣) is proportional to the extinction coefficient. 
Plotting 𝛼(ℎ𝑣) provides a linear change. The bandgap 𝐸𝑔 is calculated using the slope (m) 











A4: Collection of Wastewater from Waterloo Wastewater Treatment Plant 
1. Talk to Technician, book the truck and have someone who has sampled there before 
attend with you 
2. Ensure the truck has the required equipment 
a. Generator 
b. pump  
c. gas for generator 
d. pickaxes  
e.  hose 





h. cooler with ice 
i. 500 mL amber bottles  
j. Maxxam bottles (if not in storage we will stop by Maxxam in the morning and 
pick some up)  
k. Markers  
At the plant, you must be wearing steel toes, hard hats, and safety vests 
3. Sign in at the desk 
4. Drive to the manhole cover. Use the pick axe to open it up. 
5. Ensure the pump is well tied off and lower it into the manhole. Turn the pump on and 
collect the samples into the required 1 L amber glass bottles. You may also have 
containers from Maxxaam that you need to fill. Ensure you follow those instructions 
closely. 
6. Keep the samples on ice.  
7. Sign out at the treatment plant office before leaving the site. 
8. You may drive straight to Maxxam to drop off their samples, then return to the 
University.  
9. Store the samples in the fridge until needed. If you are not preserving them, they 
should be used within 48 hours of sampling.  








A5: Pharmaceutical Degradation Test 
Reactor Settings: UV-LED; 2 ug/L suspension; -60 min dark, 0, 5, 10, 20, 40, 60, 
90, 120 min UV-LED 
1. Prepare spike solution and apparatus ahead of time. 
a. Ensure availability of 10 mg/L regular standard stock solution. 
b. Ensure availability of 100 µg/L deuterated standard stock solution. 
c. Ensure availability of reconstitution solution. 
2. Check UV-LEDs and ensure they are working properly. 
3. Pipette 60 uL of stock solution in 3 beakers 
4. Turn on laminar flow hood and place the beakers in the fume hood. Wait until 
solution dries. 
5. Meanwhile, measure three 30 mg of designated TiO2 powder in a paper weighing 
boat.  
6. If the stock solution is dry, fill the beakers with either 300mL of Milli-Q or 
Wastewater Effluent (filtered). Place the beakers on the stir plate. Add P25. Stir high 
for 5 min. 
7. Take the first set of samples by pipetting 4.5 mL into labelled test tubes (-60 min dark 
in this case). Set timer for 60 min.  
8. Place samples in test tube racks covered with aluminum foil in the glass fridge (4oC). 
9. Take the 2nd set of samples at time=0 min and turn on UV-LED lamps. 
10. Take the next set of samples at the following time intervals: 
a. -60, 0, 5, 10, 20, 40, 60, 90, 120 
11. Meanwhile, centrifuge the samples and transfer 4 mL into another set of test tubes.  
12. At time = 60 min, prepare the MS1, MS2, and blank. Here are the components of 
each: 
a. MS1 & MS2 – 4 mL Milli-Q water, add 32 µL of 100 µg/L regular standard 
and 32 µL of 100 µg/L deuterated standard. 




13. Once all the sample sets are complete, spike new 4mL aliquots with 32 µL of 100 
µg/L standard.  






A6: Solid Phase Extraction of Pharmaceuticals  
The rocket evaporator 
only holds 18 test tubes at a time. 
For each elution batch, an MS1, 
MS2 and blank must be added. 
Additional tips: 
- Use Axygen tips (the holes are 
larger -> easier to pipette 
rapidly) 
- Use correct size test-tubes 
A. Sample Preparation
Filtration 
- Filter each sample bottle 
- Rinse apparatus between 
samples
TiO2 Test and sampling
- Measure 300 mL of WWTP water and add 30 mg 
powder (3 replicates)
-Sample 4.5 mL at each timepoint
- Centrifuge samples at 3500g for 15 min
-Transfer 4 mL to new testtubes 
MS1 & 2
- 4 mL of MilliQ H2O
- Spike 32 uL of 100 ug/L of d-Pharmamix
- Spike 32 uL of 100 ug/L of Pharmamix
Blank 
- 4 mL of MilliQ H2O
- Spike 32 uL of 100 ug/L of d-Pharmamix
Samples
- Spike 32 uL of 100 ug/L d-Pharmamix
B.  Sample 
Extraction
Preconditioning
- Oasis HLB, 1cc, 30 mg
- 1 mL MTBE
- 1 mL of Methanol
- 1 mL of MilliQ
Sample Introduction
- Pipette samples 1 mL at a time
- Rinse test tubes with 1 mL water when 
empty, vortex andload the rinse
- Rinse cartridge with 1 mL water
Sample Elution
- Clean and dry vacuum manifold 
and wait 15 min
- Place test tubes in rack inside 
manifold
- 1 mL MeOH
- 1 mL 10:90 MeOH:MTBE
Sample Evaporation
- Evaporate to dryness using the 
rocket evaporator
Reconstitution
- Pipette 160 uL of 75 ug/L 
Reconstitution Solution into each 
sample
- Vortex
- Transfer 160 uL to 2mL vial + insert
Storage




Appendix B: Additional Characterization of Ag-ZnO Particles 
B1: SEM Images and XPS Data 
 
Figure B 1: SEM image of a 50 molar percent loading of silver. 
 






Figure B 3: SEM image of agglomerate of 50 molar % silver loading at a high 
magnification. 
 





Figure B 5: SEM image of 100 molar percent silver loading at low magnification. 
  














0.04 0.00014 18.36 1.29 SiO2 Yes 
Si K 
series 
0.00 0.00002 2.24 0.65 SiO2 Yes 
Zn L 
series 
0.07 0.00073 79.41 1.39 Zn Yes 








Table B 2: XPS for a 100 molar % Ag-ZnO nanoparticle. Even with a search for Ag, 













0.18 0.00059 17.46 0.59 SiO2 Yes 
Si K 
series 
0.00 0.00003 0.95 0.27 SiO2 Yes 
Zn L 
series 
0.34 0.00342 81.59 0.63 Zn Yes 
Ag L 
series 
0.00 0.00000 0.00 0.82 Ag Yes 
 
B3: DRS Data 
The following data from the line of best fit is tabulated below, with the calculated bandgap. 
A linear regression found no significant change in bandgap. 
Table B 3: Diffuse Reflectance Spectroscopy lines of best fit and calculated adsorption 
bandgap. 
Molar Percentage Slope Intercept Bandgap R^2 
1 9.36 -30.77 377.35 0.96 
3 11.57 -37.76 379.81 0.93 
5 13.63 -43.78 385.99 0.93 
10 12.43 -40.56 379.94 0.93 
15 11.06 -36.30 377.81 0.93 
25 11.44 -37.26 380.49 0.93 
50 13.28 -43.37 379.70 0.94 
100 12.81 -41.77 380.23 0.92 
14000 13.53 -44.01 381.03 0.93 
42000 14.54 -47.29 381.12 0.93 




Molar Percentage Slope Intercept Bandgap R^2 
140000 16.92 -55.33 379.21 0.92 
210000 13.77 -44.86 380.46 0.93 
350000 17.78 -58.25 378.46 0.94 
700000 6.65 -20.90 394.23 0.88 
1050000 17.08 -55.72 380.03 0.86 
1400000 36.05 -121.33 368.41 0.99  
  Average: 380.26 0.93 
B4: Failure of pseudo- first order TPA conversion model 
Typically, the conversion of HTPA is modelled using a pseudo-first order reaction 
kinetics model, Equation B1. This reaction model was appropriate for low silver 
concentrations (Figure B6) but failed to properly represent the conversion experienced at 
high silver ratios (Figure B7). It is estimated that at a high silver ratio, the rate of degradation 
becomes dominant. At this stage the HTPA is further degraded into different by-products, 
which were not identified by our tests.  
[𝑯𝑻𝑷𝑨] =  
𝒌𝟏
𝒌𝟐





Figure B 6: The conversion of TPA into 2-HTPA by 0.0018 wt.% AgZnO 
photocatalyst over time. The curve of fit normally used for TPA tests succeeds here, 
even when the model is fit to 300 minutes. 
 
Figure B 7: The conversion of TPA into 2-HTPA over time using a 10.13 wt.% AgZnO 
composite. The pseudo-first order reaction rate model fails here. There is a clear 



























































Appendix C: Pharmaceutical Data 
C1: Degradation Plots 
 
Figure C 1: Degradation of acetaminophen in Milli-Q.
 

























































Figure C 3: Degradation of atenolol in Milli-Q. 
 


























































Figure C 5: Degradation of atorvastatin in Milli-Q. 
 

























































Figure C 7: Degradation of atrazine in Milli-Q. 
 























































Figure C 9:  Degradation of bisphenol a in Milli-Q. 
 





















































Figure C 11: Degradation of caffeine in Milli-Q. 
 

























































Figure C 13: Degradation of carbamazepine in Milli-Q. 
 

























































Figure C 15: Degradation of carbamazepine- 10,11- epoxide in Milli-Q. 
 


























































Figure C 17: Degradation of desvenlafaxine in Milli-Q. 
 
























































Figure C 19: Degradation of diclofenac in Milli-Q. 
 


























































Figure C 21: Degradation of fluoxetine in Milli-Q. 
 

























































Figure C 23: Degradation of gemfibrozil in Milli-Q. 
 

























































Figure C 25: Degradation of ibuprofen in Milli-Q. 
 

























































Figure C 27: Degradation of lincomycin in Milli-Q. 
 

























































Figure C 29: Degradation of monensin in Milli-Q. 
 

























































Figure C 31: Degradation of naproxen in Milli-Q. 
 


























































Figure C 33: Degradation of norfluoxetine in Milli-Q. 
 

























































Figure C 35: Degradation of o-atorvastatin in Milli-Q. 
 
























































Figure C 37: Degradation of p-atorvastatin in Milli-Q. 
 
























































Figure C 39: Degradation of sulfamethoxazole in Milli-Q. 
 

























































Figure C 41: Degradation of sulfanilamide in Milli-Q. 
 

























































Figure C 43: Degradation of triclosan in Milli-Q. 
 


























































Figure C 45: Degradation of trimethoprim in Milli-Q. 
 




























































Figure C 47: Degradation of venlafaxine in Milli-Q. 
 


























































C2: Statistical Data 
SAMPLE NAME TEST E/S/D/B E/S/UV/B E/S/UV/P25 M/S/D/P25 M/S/UV/B M/S/UV/P25 
Acetaminophen  k -7.06E-
04 
3.05E-03 - 1.48E-03 7.15E-03 - 
 
r^2 2.81E-01 2.95E-01 - 3.50E-01 9.88E-01 - 
  F 2.34E+00 2.51E+00 - 3.23E+00 5.04E+02 -  
Statistical 
Pass? 
Fail Fail N/A Fail Pass N/A 
Atrazine k -4.62E-
04 
1.76E-03 3.03E-03 -6.88E-04 2.39E-03 3.62E-02 
 
r^2 2.56E-01 3.22E-01 8.09E-01 3.38E-01 9.54E-01 9.87E-01 
  F 2.07E+00 2.85E+00 2.54E+01 3.07E+00 1.23E+02 4.43E+02  
Statistical 
Pass? 
Fail Fail Pass Fail Pass Pass 
Atenolol k 3.46E-04 1.90E-03 1.07E-02 -3.79E-04 4.84E-03 5.16E-02  
r^2 8.93E-02 4.66E-01 9.61E-01 2.67E-01 9.51E-01 9.40E-01 
  F 5.88E-01 5.24E+00 1.47E+02 2.19E+00 1.16E+02 9.38E+01  
Statistical 
Pass? 
Fail Fail Pass Fail Pass Pass 
Atorvastatin k 1.36E-03 1.41E-02 5.22E-02 4.80E-03 1.88E-02 1.41E+00  
r^2 6.47E-01 9.00E-01 9.94E-01 9.30E-01 9.07E-01 1.00E+00 
  F 1.10E+01 5.42E+01 9.62E+02 7.97E+01 5.83E+01 -  
Statistical 
Pass? 
Pass Pass Pass Pass Pass N/A 
BisphenolA k 3.29E-04 3.29E-03 2.96E-02 -9.16E-04 7.35E-03 1.47E+00  
r^2 2.39E-02 6.84E-01 9.64E-01 3.21E-02 9.89E-01 1.00E+00 
  F 1.47E-01 1.30E+01 1.62E+02 1.99E-01 5.43E+02 -!  
Statistical 
Pass? 
Fail Pass Pass Fail Pass N/A 
Caffeine k 2.06E-03 4.24E-04 9.67E-03 5.94E-04 1.70E-03 3.73E-02  
r^2 5.49E-01 1.59E-02 8.72E-01 5.43E-02 4.43E-01 2.72E-01 
  F 7.31E+00 9.69E-02 4.08E+01 3.45E-01 4.77E+00 2.25E+00  
Statistical 
Pass? 
Pass Fail Pass Fail Fail Fail 
Carbamazepine k -2.31E-
05 





r^2 1.25E-03 5.98E-01 9.86E-01 2.22E-02 9.77E-01 5.38E-01 
  F 7.48E-03 8.94E+00 4.36E+02 1.36E-01 2.53E+02 6.98E+00  
Statistical 
Pass? 
Fail Pass Pass Fail Pass Pass 
Carbamazepine- 
10,11-Epoxide 
k 3.06E-05 1.90E-03 1.15E-02 -4.44E-04 3.00E-03 4.10E-02 
 
r^2 1.04E-03 4.10E-01 9.68E-01 2.05E-01 9.11E-01 7.41E-01 
  F 6.28E-03 4.16E+00 1.81E+02 1.55E+00 6.15E+01 1.72E+01  
Statistical 
Pass? 
Fail Fail Pass Fail Pass Pass 
Desvenlafaxine k -2.38E-
03 
-9.85E-05 3.26E-02 -2.40E-03 5.98E-03 - 
 
r^2 8.54E-01 5.64E-03 9.68E-01 8.69E-01 9.97E-01 - 
  F 3.50E+01 3.40E-02 1.84E+02 3.97E+01 1.76E+03 -  
Statistical 
Pass? 
Pass Fail Pass Pass Pass N/A 
Diclofenac k 1.74E-03 5.47E-03 1.84E-02 1.76E-03 1.38E-02 1.45E+00  
r^2 5.49E-03 9.03E-01 7.89E-01 1.06E-01 9.97E-01 1.00E+00 
  F 3.31E-02 5.58E+01 2.25E+01 7.10E-01 1.72E+03 -!  
Statistical 
Pass? 
Fail Pass Pass Fail Pass N/A 
Flouxitine k 1.34E-04 1.75E-03 1.37E-02 8.96E-04 1.85E-02 3.39E-02  
r^2 3.47E-03 2.62E-01 9.55E-01 1.97E-01 9.79E-01 6.87E-01 
  F 2.09E-02 2.13E+00 1.26E+02 1.47E+00 2.78E+02 1.32E+01  
Statistical 
Pass? 
Fail Fail Pass Fail Pass Pass 
Gemfibrozil k 6.98E-04 3.24E-03 1.25E-02 2.93E-04 6.58E-03 -  
r^2 2.52E-01 5.11E-01 9.47E-01 2.93E-02 9.36E-01 - 
  F 2.02E+00 6.27E+00 1.07E+02 1.81E-01 8.84E+01 -  
Statistical 
Pass? 
Fail Pass Pass Fail Pass N/A 
Ibuprofen  k 0.00E+00 1.57E-03 1.14E-02 5.89E-04 3.34E-03 3.88E-01  
r^2 1.34E-02 2.43E-01 9.51E-01 3.55E-01 7.63E-01 9.14E-01 
  F 8.18E-02 1.92E+00 1.16E+02 3.30E+00 1.93E+01 2.13E+01  
Statistical 
Pass? 
Fail Fail Pass Fail Pass Pass 
Lincomycin k 2.32E-04 3.64E-03 5.25E-02 -1.34E-04 8.35E-03 3.63E-02  
r^2 2.61E-01 7.44E-01 9.92E-01 4.23E-02 9.92E-01 2.86E-01 







Fail Pass Pass Fail Pass Fail 
Monensin k -1.99E-
03 
3.56E-03 1.76E-02 3.17E-03 2.70E-02 - 
 
r^2 6.85E-01 6.46E-01 9.56E-01 7.60E-01 9.87E-01 - 
  F 1.31E+01 1.10E+01 1.29E+02 1.90E+01 4.48E+02 -  
Statistical 
Pass? 
Pass Pass Pass Pass Pass N/A 
Naproxen k 4.40E-04 5.86E-03 3.92E-02 -1.95E-03 7.58E-03 1.14E+00  
r^2 2.72E-02 7.48E-01 9.60E-01 3.02E-01 9.43E-01 1.00E+00 
  F 1.68E-01 1.78E+01 1.45E+02 2.60E+00 9.87E+01 -!  
Statistical 
Pass? 
Fail Pass Pass Fail Pass N/A 
Norfluoxetine k 8.32E-04 3.83E-03 1.46E-02 1.80E-03 1.94E-02 3.21E-02  
r^2 1.06E-01 6.53E-01 9.32E-01 5.24E-01 9.90E-01 7.40E-01 
  F 7.12E-01 1.13E+01 8.19E+01 6.61E+00 5.94E+02 1.71E+01  
Statistical 
Pass? 
Fail Pass Pass Pass Pass Pass 
O-Atorvastatin k 7.61E-04 1.75E-02 4.99E-02 1.45E-02 2.40E-02 -  
r^2 5.71E-01 9.59E-01 7.92E-01 8.71E-01 8.81E-01 - 
  F 7.98E+00 1.42E+02 2.29E+01 4.04E+01 4.43E+01 -  
Statistical 
Pass? 
Pass Fail Pass Pass Pass Pass 
P-Atorvastatin k 6.78E-04 1.51E-02 - 1.11E-02 2.31E-02 -  
r^2 3.36E-01 9.49E-01 - 9.70E-01 9.49E-01 - 
  F 3.04E+00 1.12E+02 - 1.92E+02 1.11E+02 -  
Statistical 
Pass? 
Fail Pass N/A Pass Pass N/A 
Sulfamethoxazole k 3.38E-04 3.68E-03 3.69E-02 7.65E-05 6.63E-03 -  
r^2 2.36E-01 6.69E-01 9.79E-01 3.14E-03 9.72E-01 - 
  F 1.85E+00 1.21E+01 2.77E+02 1.89E-02 2.12E+02 -  
Statistical 
Pass? 
Fail Pass Pass Fail Pass N/A 
Sulfonamide k -1.26E-
03 
- 2.52E-02 -2.04E-03 2.97E-03 - 
 
r^2 4.44E-01 - 9.89E-01 9.18E-01 9.38E-01 - 
  F 4.78E+00 - 5.49E+02 6.70E+01 9.13E+01 -  
Statistical 
Pass? 






3.05E-03 3.44E-02 -8.51E-04 9.38E-03 7.73E-01 
 
r^2 6.27E-04 5.82E-01 9.05E-01 5.26E-02 9.93E-01 9.84E-01 
  F 3.77E-03 8.36E+00 5.72E+01 3.33E-01 8.57E+02 6.25E+01  
Statistical 
Pass? 
Fail Pass Pass Fail Pass Pass 
Trimethoprim k -3.80E-
04 
1.62E-03 1.38E-02 -1.13E-03 9.10E-03 3.98E-02 
 
r^2 3.13E-01 4.05E-01 9.80E-01 6.47E-01 9.95E-01 7.47E-01 
  F 2.73E+00 4.09E+00 2.87E+02 1.10E+01 1.19E+03 1.78E+01  
Statistical 
Pass? 
Fail Fail Pass Pass Pass Pass 
Venlafaxine k -1.06E-
03 
2.12E-04 1.21E-02 -1.42E-03 7.98E-03 4.54E-02 
 
r^2 5.95E-01 1.92E-02 9.59E-01 6.46E-01 9.96E-01 7.02E-01 
  F 8.82E+00 1.17E-01 1.41E+02 1.10E+01 1.47E+03 1.42E+01  
Statistical 
Pass? 
Pass Pass Pass Pass Pass N/A 
 
